{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T18:31:28Z","timestamp":1795026688863,"version":"4.10.2"},"reference-count":397,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T00:00:00Z","timestamp":1705017600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T00:00:00Z","timestamp":1705017600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["1 ZIAAA000036"],"award-info":[{"award-number":["1 ZIAAA000036"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>This review provides an update on recent findings from basic, translational, and clinical studies on the molecular mechanisms of mitochondrial dysfunction and apoptosis of hepatocytes in multiple liver diseases, including but not limited to alcohol-associated liver disease (ALD), metabolic dysfunction-associated steatotic liver disease (MASLD), and drug-induced liver injury (DILI). While the ethanol-inducible cytochrome P450-2E1 (CYP2E1) is mainly responsible for oxidizing binge alcohol via the microsomal ethanol oxidizing system, it is also responsible for metabolizing many xenobiotics, including pollutants, chemicals, drugs, and specific diets abundant in n-6 fatty acids, into toxic metabolites in many\u00a0organs, including the liver, causing pathological insults through organelles such as mitochondria and endoplasmic reticula. Oxidative imbalances (oxidative stress) in mitochondria promote the covalent modifications of lipids, proteins, and nucleic acids through enzymatic and non-enzymatic mechanisms. Excessive changes stimulate various post-translational modifications (PTMs) of mitochondrial proteins, transcription factors, and histones. Increased PTMs of mitochondrial proteins inactivate many enzymes involved in the\u00a0reduction of oxidative species, fatty acid metabolism, and mitophagy pathways, leading to mitochondrial dysfunction, energy depletion, and apoptosis. Unique from other organelles, mitochondria control many signaling cascades involved in bioenergetics (fat metabolism), inflammation, and apoptosis\/necrosis of hepatocytes. When mitochondrial homeostasis is shifted, these pathways become altered or shut down, likely contributing to the death of hepatocytes with activation of inflammation and hepatic stellate cells, causing liver fibrosis and cirrhosis. This review will encapsulate how mitochondrial dysfunction contributes to hepatocyte apoptosis in several types of liver diseases\u00a0in order to provide recommendations for targeted therapeutics.<\/jats:p>","DOI":"10.1007\/s00018-023-05061-7","type":"journal-article","created":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T00:02:03Z","timestamp":1705017723000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":221,"title":["Contributing roles of mitochondrial dysfunction and hepatocyte apoptosis in liver diseases through oxidative stress, post-translational modifications, inflammation, and intestinal barrier dysfunction"],"prefix":"10.1007","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-4084-3082","authenticated-orcid":false,"given":"Karli R.","family":"LeFort","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9334-0984","authenticated-orcid":false,"given":"Wiramon","family":"Rungratanawanich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3954-3497","authenticated-orcid":false,"given":"Byoung-Joon","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,12]]},"reference":[{"issue":"3","key":"5061_CR1","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1124\/jpet.112.192120","volume":"342","author":"RK Naviaux","year":"2012","unstructured":"Naviaux RK (2012) Oxidative shielding or oxidative stress? J Pharmacol Exp Ther 342(3):608\u2013618","journal-title":"J Pharmacol Exp Ther"},{"issue":"13","key":"5061_CR2","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1089\/ars.2017.7373","volume":"28","author":"P Rada","year":"2018","unstructured":"Rada P et al (2018) SIRT1 controls acetaminophen hepatotoxicity by modulating inflammation and oxidative stress. Antioxid Redox Signal 28(13):1187\u20131208","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"5061_CR3","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1039\/C7TX00166E","volume":"7","author":"LY Zhu","year":"2018","unstructured":"Zhu LY et al (2018) Involvement of histone hypoacetylation in INH-induced rat liver injury. Toxicol Res (Camb) 7(1):41\u201347","journal-title":"Toxicol Res (Camb)"},{"issue":"4","key":"5061_CR4","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1002\/cpt.564","volume":"101","author":"M Mosedale","year":"2017","unstructured":"Mosedale M, Watkins PB (2017) Drug-induced liver injury: advances in mechanistic understanding that will inform risk management. Clin Pharmacol Ther 101(4):469\u2013480","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"5061_CR5","doi-asserted-by":"publisher","first-page":"7336","DOI":"10.1038\/s41598-022-10857-x","volume":"12","author":"S Hiemstra","year":"2022","unstructured":"Hiemstra S et al (2022) Dynamic modeling of Nrf2 pathway activation in liver cells after toxicant exposure. Sci Rep 12(1):7336","journal-title":"Sci Rep"},{"issue":"15","key":"5061_CR6","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1016\/j.lfs.2005.04.013","volume":"77","author":"H Wang","year":"2005","unstructured":"Wang H et al (2005) Melatonin ameliorates carbon tetrachloride-induced hepatic fibrogenesis in rats via inhibition of oxidative stress. Life Sci 77(15):1902\u20131915","journal-title":"Life Sci"},{"issue":"4","key":"5061_CR7","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/hep.21097","volume":"43","author":"SK Natarajan","year":"2006","unstructured":"Natarajan SK et al (2006) Intestinal mucosal alterations in rats with carbon tetrachloride-induced cirrhosis: changes in glycosylation and luminal bacteria. Hepatology 43(4):837\u2013846","journal-title":"Hepatology"},{"issue":"8","key":"5061_CR8","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1021\/tx960181b","volume":"10","author":"DP Hartley","year":"1997","unstructured":"Hartley DP, Kroll DJ, Petersen DR (1997) Prooxidant-initiated lipid peroxidation in isolated rat hepatocytes: detection of 4-hydroxynonenal- and malondialdehyde-protein adducts. Chem Res Toxicol 10(8):895\u2013905","journal-title":"Chem Res Toxicol"},{"issue":"47","key":"5061_CR9","doi-asserted-by":"publisher","first-page":"17756","DOI":"10.3748\/wjg.v20.i47.17756","volume":"20","author":"E Ceni","year":"2014","unstructured":"Ceni E, Mello T, Galli A (2014) Pathogenesis of alcoholic liver disease: role of oxidative metabolism. World J Gastroenterol 20(47):17756\u201317772","journal-title":"World J Gastroenterol"},{"key":"5061_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102577","volume":"59","author":"W Rungratanawanich","year":"2023","unstructured":"Rungratanawanich W et al (2023) ALDH2 deficiency increases susceptibility to binge alcohol-induced gut leakiness, endotoxemia, and acute liver injury in mice through the gut\u2013liver axis. Redox Biol 59:102577","journal-title":"Redox Biol"},{"key":"5061_CR11","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/j.freeradbiomed.2013.09.009","volume":"65","author":"MA Abdelmegeed","year":"2013","unstructured":"Abdelmegeed MA et al (2013) CYP2E1 potentiates binge alcohol-induced gut leakiness, steatohepatitis, and apoptosis. Free Radic Biol Med 65:1238\u20131245","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"5061_CR12","doi-asserted-by":"publisher","first-page":"774","DOI":"10.3390\/ijms23020774","volume":"23","author":"YM Yang","year":"2022","unstructured":"Yang YM, Cho YE, Hwang S (2022) Crosstalk between oxidative stress and inflammatory liver injury in the pathogenesis of alcoholic liver disease. Int J Mol Sci 23(2):774","journal-title":"Int J Mol Sci"},{"issue":"6","key":"5061_CR13","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s00424-018-02250-3","volume":"471","author":"SK Shin","year":"2019","unstructured":"Shin SK et al (2019) Ablation of catalase promotes non-alcoholic fatty liver via oxidative stress and mitochondrial dysfunction in diet-induced obese mice. Pflugers Arch 471(6):829\u2013843","journal-title":"Pflugers Arch"},{"issue":"2","key":"5061_CR14","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3390\/medicina55020026","volume":"55","author":"A Ore","year":"2019","unstructured":"Ore A, Akinloye OA (2019) Oxidative stress and antioxidant biomarkers in clinical and experimental models of non-alcoholic fatty liver disease. Medicina (Kaunas) 55(2):26","journal-title":"Medicina (Kaunas)"},{"issue":"6","key":"5061_CR15","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.3390\/antiox11061131","volume":"11","author":"A Nasc\u00e8","year":"2022","unstructured":"Nasc\u00e8 A et al (2022) NADPH oxidases connecting fatty liver disease, insulin resistance and type 2 diabetes: current knowledge and therapeutic outlook. Antioxidants (Basel) 11(6):1131","journal-title":"Antioxidants (Basel)"},{"issue":"3","key":"5061_CR16","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1053\/j.gastro.2018.06.083","volume":"155","author":"A Mansouri","year":"2018","unstructured":"Mansouri A, Gattolliat CH, Asselah T (2018) Mitochondrial dysfunction and signaling in chronic liver diseases. Gastroenterology 155(3):629\u2013647","journal-title":"Gastroenterology"},{"issue":"11","key":"5061_CR17","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s12272-019-01178-1","volume":"42","author":"J Lee","year":"2019","unstructured":"Lee J, Park JS, Roh YS (2019) Molecular insights into the role of mitochondria in non-alcoholic fatty liver disease. Arch Pharm Res 42(11):935\u2013946","journal-title":"Arch Pharm Res"},{"key":"5061_CR18","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.freeradbiomed.2020.02.025","volume":"152","author":"Z Chen","year":"2020","unstructured":"Chen Z et al (2020) Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease. Free Radic Biol Med 152:116\u2013141","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"5061_CR19","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3390\/antiox10020174","volume":"10","author":"JC Arroyave-Ospina","year":"2021","unstructured":"Arroyave-Ospina JC et al (2021) Role of oxidative stress in the pathogenesis of non-alcoholic fatty liver disease: implications for prevention and therapy. Antioxidants (Basel) 10(2):174","journal-title":"Antioxidants (Basel)"},{"issue":"12","key":"5061_CR20","doi-asserted-by":"publisher","first-page":"4484","DOI":"10.3390\/nu13124484","volume":"13","author":"W Zheng","year":"2021","unstructured":"Zheng W et al (2021) Protective effects of sesamol against liver oxidative stress and inflammation in high-fat diet-induced hepatic steatosis. Nutrients 13(12):4484","journal-title":"Nutrients"},{"issue":"8","key":"5061_CR21","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1017\/S0007114519001466","volume":"122","author":"A Yildirim","year":"2019","unstructured":"Yildirim A et al (2019) The effects of antibiotics and melatonin on hepato-intestinal inflammation and gut microbial dysbiosis induced by a short-term high-fat diet consumption in rats. Br J Nutr 122(8):841\u2013855","journal-title":"Br J Nutr"},{"key":"5061_CR22","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jnutbio.2016.08.013","volume":"38","author":"Y Choi","year":"2016","unstructured":"Choi Y, Abdelmegeed MA, Song BJ (2016) Preventive effects of dietary walnuts on high-fat-induced hepatic fat accumulation, oxidative stress and apoptosis in mice. J Nutr Biochem 38:70\u201380","journal-title":"J Nutr Biochem"},{"issue":"5","key":"5061_CR23","doi-asserted-by":"publisher","first-page":"939","DOI":"10.14218\/JCTH.2022.00067","volume":"10","author":"K Clare","year":"2022","unstructured":"Clare K, Dillon JF, Brennan PN (2022) Reactive oxygen species and oxidative stress in the pathogenesis of MAFLD. J Clin Transl Hepatol 10(5):939\u2013946","journal-title":"J Clin Transl Hepatol"},{"key":"5061_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2020.101710","volume":"37","author":"MC Podszun","year":"2020","unstructured":"Podszun MC et al (2020) Vitamin E treatment in NAFLD patients demonstrates that oxidative stress drives steatosis through upregulation of de-novo lipogenesis. Redox Biol 37:101710","journal-title":"Redox Biol"},{"issue":"4","key":"5061_CR25","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1164\/rccm.200206-518OC","volume":"167","author":"HB Suliman","year":"2003","unstructured":"Suliman HB, Carraway MS, Piantadosi CA (2003) Postlipopolysaccharide oxidative damage of mitochondrial DNA. Am J Respir Crit Care Med 167(4):570\u2013579","journal-title":"Am J Respir Crit Care Med"},{"key":"5061_CR26","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.redox.2014.10.004","volume":"3","author":"BJ Song","year":"2014","unstructured":"Song BJ et al (2014) Mitochondrial dysfunction and tissue injury by alcohol, high fat, nonalcoholic substances and pathological conditions through post-translational protein modifications. Redox Biol 3:109\u2013123","journal-title":"Redox Biol"},{"issue":"8","key":"5061_CR27","doi-asserted-by":"publisher","first-page":"5128","DOI":"10.1074\/jbc.M510484200","volume":"281","author":"J Bai","year":"2006","unstructured":"Bai J, Cederbaum AI (2006) Overexpression of CYP2E1 in mitochondria sensitizes HepG2 cells to the toxicity caused by depletion of glutathione. J Biol Chem 281(8):5128\u20135136","journal-title":"J Biol Chem"},{"issue":"17","key":"5061_CR28","doi-asserted-by":"publisher","first-page":"12912","DOI":"10.1016\/S0021-9258(18)31472-8","volume":"268","author":"RM Laethem","year":"1993","unstructured":"Laethem RM et al (1993) Formation of 19(S)-, 19(R)-, and 18(R)-hydroxyeicosatetraenoic acids by alcohol-inducible cytochrome P450 2E1. J Biol Chem 268(17):12912\u201312918","journal-title":"J Biol Chem"},{"key":"5061_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112891","volume":"209","author":"AM Pisoschi","year":"2021","unstructured":"Pisoschi AM et al (2021) Oxidative stress mitigation by antioxidants\u2014an overview on their chemistry and influences on health status. Eur J Med Chem 209:112891","journal-title":"Eur J Med Chem"},{"key":"5061_CR30","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ejmech.2015.04.040","volume":"97","author":"AM Pisoschi","year":"2015","unstructured":"Pisoschi AM, Pop A (2015) The role of antioxidants in the chemistry of oxidative stress: a review. Eur J Med Chem 97:55\u201374","journal-title":"Eur J Med Chem"},{"key":"5061_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2020.108698","volume":"702","author":"J Johnson","year":"2021","unstructured":"Johnson J et al (2021) Mitochondrial dysfunction in the development and progression of neurodegenerative diseases. Arch Biochem Biophys 702:108698","journal-title":"Arch Biochem Biophys"},{"issue":"2","key":"5061_CR32","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.chest.2019.08.2182","volume":"157","author":"GS Supinski","year":"2020","unstructured":"Supinski GS, Schroder EA, Callahan LA (2020) Mitochondria and critical illness. Chest 157(2):310\u2013322","journal-title":"Chest"},{"key":"5061_CR33","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/978-1-0716-1266-8_16","volume":"2276","author":"V Gogvadze","year":"2021","unstructured":"Gogvadze V, Zhivotovsky B (2021) Analysis of mitochondrial dysfunction during cell death. Methods Mol Biol 2276:215\u2013225","journal-title":"Methods Mol Biol"},{"issue":"284","key":"5061_CR34","first-page":"124","volume":"48","author":"K Jakubczyk","year":"2020","unstructured":"Jakubczyk K et al (2020) Reactive oxygen species\u2014sources, functions, oxidative damage. Pol Merkur Lekarski 48(284):124\u2013127","journal-title":"Pol Merkur Lekarski"},{"issue":"1","key":"5061_CR35","first-page":"16","volume":"20","author":"H Alkadi","year":"2020","unstructured":"Alkadi H (2020) A review on free radicals and antioxidants. Infect Disord Drug Targets 20(1):16\u201326","journal-title":"Infect Disord Drug Targets"},{"key":"5061_CR36","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/112_2018_10","volume":"175","author":"T Luangmonkong","year":"2018","unstructured":"Luangmonkong T et al (2018) Targeting oxidative stress for the treatment of liver fibrosis. Rev Physiol Biochem Pharmacol 175:71\u2013102","journal-title":"Rev Physiol Biochem Pharmacol"},{"issue":"29","key":"5061_CR37","doi-asserted-by":"publisher","first-page":"3780","DOI":"10.3748\/wjg.v28.i29.3780","volume":"28","author":"N Gligorijevi\u0107","year":"2022","unstructured":"Gligorijevi\u0107 N, Mini\u0107 S, Nedi\u0107 O (2022) Structural changes of proteins in liver cirrhosis and consequential changes in their function. World J Gastroenterol 28(29):3780\u20133792","journal-title":"World J Gastroenterol"},{"issue":"1","key":"5061_CR38","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12943-018-0856-3","volume":"17","author":"Y Liu","year":"2018","unstructured":"Liu Y et al (2018) Critical role of FOXO3a in carcinogenesis. Mol Cancer 17(1):104","journal-title":"Mol Cancer"},{"issue":"2","key":"5061_CR39","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1002\/pmic.201000203","volume":"11","author":"VV Upreti","year":"2011","unstructured":"Upreti VV et al (2011) Increased oxidative-modifications of cytosolic proteins in 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)-exposed rat liver. Proteomics 11(2):202\u2013211","journal-title":"Proteomics"},{"issue":"3\u20134","key":"5061_CR40","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1081\/DMR-200033441","volume":"36","author":"CS Lieber","year":"2004","unstructured":"Lieber CS (2004) The discovery of the microsomal ethanol oxidizing system and its physiologic and pathologic role. Drug Metab Rev 36(3\u20134):511\u2013529","journal-title":"Drug Metab Rev"},{"issue":"3","key":"5061_CR41","doi-asserted-by":"publisher","first-page":"207","DOI":"10.2174\/1874467208666150817111114","volume":"10","author":"MA Abdelmegeed","year":"2017","unstructured":"Abdelmegeed MA et al (2017) Role of CYP2E1 in mitochondrial dysfunction and hepatic injury by alcohol and non-alcoholic substances. Curr Mol Pharmacol 10(3):207\u2013225","journal-title":"Curr Mol Pharmacol"},{"issue":"4","key":"5061_CR42","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1021\/acs.jproteome.8b00800","volume":"18","author":"HR Ali","year":"2019","unstructured":"Ali HR et al (2019) Quantifying competition among mitochondrial protein acylation events induced by ethanol metabolism. J Proteome Res 18(4):1513\u20131531","journal-title":"J Proteome Res"},{"issue":"2","key":"5061_CR43","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1172\/JCI85499","volume":"127","author":"S Stein","year":"2017","unstructured":"Stein S et al (2017) Impaired SUMOylation of nuclear receptor LRH-1 promotes nonalcoholic fatty liver disease. J Clin Invest 127(2):583\u2013592","journal-title":"J Clin Invest"},{"issue":"7","key":"5061_CR44","doi-asserted-by":"publisher","first-page":"G497","DOI":"10.1152\/ajpgi.00178.2015","volume":"310","author":"J Martin","year":"2016","unstructured":"Martin J et al (2016) Nutritional stress exacerbates hepatic steatosis induced by deletion of the histidine nucleotide-binding (Hint2) mitochondrial protein. Am J Physiol Gastrointest Liver Physiol 310(7):G497-509","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"1","key":"5061_CR45","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1038\/s41598-017-02159-4","volume":"7","author":"LF Shen","year":"2017","unstructured":"Shen LF et al (2017) Role of S-palmitoylation by ZDHHC13 in mitochondrial function and metabolism in liver. Sci Rep 7(1):2182","journal-title":"Sci Rep"},{"issue":"7","key":"5061_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111194","volume":"40","author":"Y Sun","year":"2022","unstructured":"Sun Y et al (2022) S-palmitoylation of PCSK9 induces sorafenib resistance in liver cancer by activating the PI3K\/AKT pathway. Cell Rep 40(7):111194","journal-title":"Cell Rep"},{"issue":"23","key":"5061_CR47","doi-asserted-by":"publisher","first-page":"13094","DOI":"10.3390\/ijms222313094","volume":"22","author":"E Ziemli\u0144ska","year":"2021","unstructured":"Ziemli\u0144ska E et al (2021) Palm oil-rich diet affects murine liver proteome and S-palmitoylome. Int J Mol Sci 22(23):13094","journal-title":"Int J Mol Sci"},{"issue":"8","key":"5061_CR48","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1080\/15548627.2021.2007027","volume":"18","author":"J Yao","year":"2022","unstructured":"Yao J et al (2022) CDK9 inhibition blocks the initiation of PINK1-PRKN-mediated mitophagy by regulating the SIRT1-FOXO3-BNIP3 axis and enhances the therapeutic effects involving mitochondrial dysfunction in hepatocellular carcinoma. Autophagy 18(8):1879\u20131897","journal-title":"Autophagy"},{"key":"5061_CR49","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/781050","volume":"2013","author":"BJ Song","year":"2013","unstructured":"Song BJ et al (2013) Increased nitroxidative stress promotes mitochondrial dysfunction in alcoholic and nonalcoholic fatty liver disease. Oxid Med Cell Longev 2013:781050","journal-title":"Oxid Med Cell Longev"},{"issue":"4","key":"5061_CR50","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/nbt.2838","volume":"32","author":"AJ Shuhendler","year":"2014","unstructured":"Shuhendler AJ et al (2014) Real-time imaging of oxidative and nitrosative stress in the liver of live animals for drug-toxicity testing. Nat Biotechnol 32(4):373\u2013380","journal-title":"Nat Biotechnol"},{"issue":"6","key":"5061_CR51","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1002\/hep.30652","volume":"73","author":"YE Cho","year":"2021","unstructured":"Cho YE et al (2021) Fructose promotes leaky gut, endotoxemia, and liver fibrosis through ethanol-inducible cytochrome P450\u20132E1-mediated oxidative and nitrative stress. Hepatology 73(6):2180\u20132195","journal-title":"Hepatology"},{"issue":"1","key":"5061_CR52","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/hep.24377","volume":"54","author":"BK Chacko","year":"2011","unstructured":"Chacko BK et al (2011) Mitochondria-targeted ubiquinone (MitoQ) decreases ethanol-dependent micro and macro hepatosteatosis. Hepatology 54(1):153\u2013163","journal-title":"Hepatology"},{"key":"5061_CR53","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.freeradbiomed.2013.02.018","volume":"60","author":"MA Abdelmegeed","year":"2013","unstructured":"Abdelmegeed MA et al (2013) Robust protein nitration contributes to acetaminophen-induced mitochondrial dysfunction and acute liver injury. Free Radic Biol Med 60:211\u2013222","journal-title":"Free Radic Biol Med"},{"issue":"4","key":"5061_CR54","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1053\/j.gastro.2008.06.048","volume":"135","author":"KH Moon","year":"2008","unstructured":"Moon KH et al (2008) Oxidative inactivation of key mitochondrial proteins leads to dysfunction and injury in hepatic ischemia reperfusion. Gastroenterology 135(4):1344\u20131357","journal-title":"Gastroenterology"},{"issue":"21","key":"5061_CR55","doi-asserted-by":"publisher","first-page":"3967","DOI":"10.1016\/j.febslet.2007.07.037","volume":"581","author":"KH Moon","year":"2007","unstructured":"Moon KH, Abdelmegeed MA, Song BJ (2007) Inactivation of cytosolic aldehyde dehydrogenase via S-nitrosylation in ethanol-exposed rat liver. FEBS Lett 581(21):3967\u20133972","journal-title":"FEBS Lett"},{"key":"5061_CR56","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.redox.2015.09.040","volume":"6","author":"S Jang","year":"2015","unstructured":"Jang S et al (2015) Critical role of c-jun N-terminal protein kinase in promoting mitochondrial dysfunction and acute liver injury. Redox Biol 6:552\u2013564","journal-title":"Redox Biol"},{"issue":"3","key":"5061_CR57","doi-asserted-by":"publisher","first-page":"63","DOI":"10.21315\/tlsr2020.31.3.5","volume":"31","author":"YH Lua","year":"2020","unstructured":"Lua YH et al (2020) Ethanol-induced CYP2E1 expression is reduced by lauric acid via PI3K pathway in HepG2 cells. Trop Life Sci Res 31(3):63\u201375","journal-title":"Trop Life Sci Res"},{"key":"5061_CR58","doi-asserted-by":"crossref","unstructured":"Chen XF et al (2018) SIRT5 inhibits peroxisomal ACOX1 to prevent oxidative damage and is downregulated in liver cancer. EMBO Rep 19(5):e45124","DOI":"10.15252\/embr.201745124"},{"issue":"1","key":"5061_CR59","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.bcp.2009.07.016","volume":"79","author":"MA Abdelmegeed","year":"2010","unstructured":"Abdelmegeed MA et al (2010) Role of cytochrome P450 2E1 in protein nitration and ubiquitin-mediated degradation during acetaminophen toxicity. Biochem Pharmacol 79(1):57\u201366","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"5061_CR60","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1002\/hep.25701","volume":"56","author":"ML Tomasi","year":"2012","unstructured":"Tomasi ML et al (2012) S-adenosyl methionine regulates ubiquitin-conjugating enzyme 9 protein expression and sumoylation in murine liver and human cancers. Hepatology 56(3):982\u2013993","journal-title":"Hepatology"},{"issue":"4","key":"5061_CR61","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1002\/hep.30917","volume":"71","author":"J Liu","year":"2020","unstructured":"Liu J et al (2020) Mesencephalic astrocyte-derived neurotrophic factor inhibits liver cancer through small ubiquitin-related modifier (SUMO)ylation-related suppression of NF-\u03baB\/snail signaling pathway and epithelial-mesenchymal transition. Hepatology 71(4):1262\u20131278","journal-title":"Hepatology"},{"issue":"6","key":"5061_CR62","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1002\/hep.31222","volume":"72","author":"X Liu","year":"2020","unstructured":"Liu X et al (2020) SIRT1 regulates N(6)-methyladenosine RNA modification in hepatocarcinogenesis by inducing RANBP2-dependent FTO SUMOylation. Hepatology 72(6):2029\u20132050","journal-title":"Hepatology"},{"key":"5061_CR63","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.cca.2020.07.044","volume":"510","author":"M Zeng","year":"2020","unstructured":"Zeng M et al (2020) Sumoylation in liver disease. Clin Chim Acta 510:347\u2013353","journal-title":"Clin Chim Acta"},{"issue":"22","key":"5061_CR64","doi-asserted-by":"publisher","first-page":"5700","DOI":"10.3390\/cancers13225700","volume":"13","author":"H Yuan","year":"2021","unstructured":"Yuan H et al (2021) The role of protein SUMOylation in human hepatocellular carcinoma: a potential target of new drug discovery and development. Cancers (Basel) 13(22):5700","journal-title":"Cancers (Basel)"},{"key":"5061_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102458","volume":"56","author":"Q Zhou","year":"2022","unstructured":"Zhou Q et al (2022) GTPBP4 promotes hepatocellular carcinoma progression and metastasis via the PKM2 dependent glucose metabolism. Redox Biol 56:102458","journal-title":"Redox Biol"},{"issue":"12","key":"5061_CR66","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1002\/jat.3666","volume":"38","author":"HN Mai","year":"2018","unstructured":"Mai HN et al (2018) Protective potential of glutathione peroxidase-1 gene against cocaine-induced acute hepatotoxic consequences in mice. J Appl Toxicol 38(12):1502\u20131520","journal-title":"J Appl Toxicol"},{"issue":"1","key":"5061_CR67","first-page":"78","volume":"49","author":"M Aranda","year":"2010","unstructured":"Aranda M et al (2010) In vivo hepatic oxidative stress because of carbon tetrachloride toxicity: protection by melatonin and pinoline. J Pineal Res 49(1):78\u201385","journal-title":"J Pineal Res"},{"issue":"4","key":"5061_CR68","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.jhep.2012.05.019","volume":"57","author":"MA Abdelmegeed","year":"2012","unstructured":"Abdelmegeed MA et al (2012) Critical role of cytochrome P450 2E1 (CYP2E1) in the development of high fat-induced non-alcoholic steatohepatitis. J Hepatol 57(4):860\u2013866","journal-title":"J Hepatol"},{"issue":"4","key":"5061_CR69","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.bbrc.2015.03.132","volume":"460","author":"Z Xu","year":"2015","unstructured":"Xu Z, Zhong L (2015) New insights into the posttranslational regulation of human cytosolic thioredoxin by S-palmitoylation. Biochem Biophys Res Commun 460(4):949\u2013956","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"5061_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2022.188735","volume":"1877","author":"G Zhu","year":"2022","unstructured":"Zhu G et al (2022) Proteomics of post-translational modifications in colorectal cancer: discovery of new biomarkers. Biochim Biophys Acta Rev Cancer 1877(4):188735","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"5061_CR71","first-page":"26050","volume":"26","author":"JM Rodr\u00edguez","year":"2015","unstructured":"Rodr\u00edguez JM et al (2015) The composition of the gut microbiota throughout life, with an emphasis on early life. Microb Ecol Health Dis 26:26050","journal-title":"Microb Ecol Health Dis"},{"key":"5061_CR72","doi-asserted-by":"crossref","unstructured":"Adhikari R et al (2023) Alcohol-induced tubulin post-translational modifications directly alter hepatic protein trafficking. Hepatol Commun 7(4):e0103","DOI":"10.1097\/HC9.0000000000000103"},{"issue":"9","key":"5061_CR73","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1111\/j.1349-7006.2012.02360.x","volume":"103","author":"Y Yukawa","year":"2012","unstructured":"Yukawa Y et al (2012) Combination of ADH1B*2\/ALDH2*2 polymorphisms alters acetaldehyde-derived DNA damage in the blood of Japanese alcoholics. Cancer Sci 103(9):1651\u20131655","journal-title":"Cancer Sci"},{"issue":"9","key":"5061_CR74","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1111\/j.1530-0277.1998.tb05925.x","volume":"22","author":"O Niemel\u00e4","year":"1998","unstructured":"Niemel\u00e4 O et al (1998) Early alcoholic liver injury: formation of protein adducts with acetaldehyde and lipid peroxidation products, and expression of CYP2E1 and CYP3A. Alcohol Clin Exp Res 22(9):2118\u20132124","journal-title":"Alcohol Clin Exp Res"},{"key":"5061_CR75","doi-asserted-by":"publisher","first-page":"4591134","DOI":"10.1155\/2022\/4591134","volume":"2022","author":"X Zhao","year":"2022","unstructured":"Zhao X et al (2022) Quercetin protects ethanol-induced hepatocyte pyroptosis via scavenging mitochondrial ROS and promoting PGC-1\u03b1-regulated mitochondrial homeostasis in L02 cells. Oxid Med Cell Longev 2022:4591134","journal-title":"Oxid Med Cell Longev"},{"issue":"3","key":"5061_CR76","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1111\/j.1530-0277.2009.01122.x","volume":"34","author":"Y Wang","year":"2010","unstructured":"Wang Y, Seitz HK, Wang XD (2010) Moderate alcohol consumption aggravates high-fat diet induced steatohepatitis in rats. Alcohol Clin Exp Res 34(3):567\u2013573","journal-title":"Alcohol Clin Exp Res"},{"issue":"33","key":"5061_CR77","doi-asserted-by":"publisher","first-page":"5677","DOI":"10.2174\/092986712803988929","volume":"19","author":"V Vitcheva","year":"2012","unstructured":"Vitcheva V (2012) Cocaine toxicity and hepatic oxidative stress. Curr Med Chem 19(33):5677\u20135682","journal-title":"Curr Med Chem"},{"issue":"2","key":"5061_CR78","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1515\/reveh-2020-0048","volume":"36","author":"V Unsal","year":"2021","unstructured":"Unsal V, Cicek M, Sabancilar \u0130 (2021) Toxicity of carbon tetrachloride, free radicals and role of antioxidants. Rev Environ Health 36(2):279\u2013295","journal-title":"Rev Environ Health"},{"issue":"3","key":"5061_CR79","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/(SICI)1522-7146(1996)11:3<139::AID-JBT6>3.0.CO;2-L","volume":"11","author":"CP Sodhi","year":"1996","unstructured":"Sodhi CP et al (1996) Study of oxidative stress in isoniazid-induced hepatic injury in young rats with and without protein-energy malnutrition. J Biochem Toxicol 11(3):139\u2013146","journal-title":"J Biochem Toxicol"},{"issue":"12","key":"5061_CR80","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1016\/j.jprot.2011.05.013","volume":"74","author":"BJ Song","year":"2011","unstructured":"Song BJ et al (2011) Post-translational modifications of mitochondrial aldehyde dehydrogenase and biomedical implications. J Proteomics 74(12):2691\u20132702","journal-title":"J Proteomics"},{"issue":"11","key":"5061_CR81","doi-asserted-by":"publisher","first-page":"3401","DOI":"10.1002\/pmic.200400971","volume":"4","author":"SK Suh","year":"2004","unstructured":"Suh SK et al (2004) Identification of oxidized mitochondrial proteins in alcohol-exposed human hepatoma cells and mouse liver. Proteomics 4(11):3401\u20133412","journal-title":"Proteomics"},{"key":"5061_CR82","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2022.116043","volume":"445","author":"OB Adelusi","year":"2022","unstructured":"Adelusi OB et al (2022) The role of iron in lipid peroxidation and protein nitration during acetaminophen-induced liver injury in mice. Toxicol Appl Pharmacol 445:116043","journal-title":"Toxicol Appl Pharmacol"},{"issue":"5","key":"5061_CR83","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1002\/hep.21372","volume":"44","author":"KH Moon","year":"2006","unstructured":"Moon KH et al (2006) Inactivation of oxidized and S-nitrosylated mitochondrial proteins in alcoholic fatty liver of rats. Hepatology 44(5):1218\u20131230","journal-title":"Hepatology"},{"key":"5061_CR84","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.cbi.2017.08.006","volume":"275","author":"F Wang","year":"2017","unstructured":"Wang F et al (2017) Apigenin protects against alcohol-induced liver injury in mice by regulating hepatic CYP2E1-mediated oxidative stress and PPAR\u03b1-mediated lipogenic gene expression. Chem Biol Interact 275:171\u2013177","journal-title":"Chem Biol Interact"},{"key":"5061_CR85","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.redox.2018.04.006","volume":"17","author":"S Wang","year":"2018","unstructured":"Wang S et al (2018) Nicotinamide riboside attenuates alcohol induced liver injuries via activation of SirT1\/PGC-1\u03b1\/mitochondrial biosynthesis pathway. Redox Biol 17:89\u201398","journal-title":"Redox Biol"},{"issue":"1","key":"5061_CR86","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jhep.2018.02.005","volume":"69","author":"YE Cho","year":"2018","unstructured":"Cho YE et al (2018) Apoptosis of enterocytes and nitration of junctional complex proteins promote alcohol-induced gut leakiness and liver injury. J Hepatol 69(1):142\u2013153","journal-title":"J Hepatol"},{"key":"5061_CR87","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.redox.2014.10.002","volume":"3","author":"CB Forsyth","year":"2014","unstructured":"Forsyth CB, Voigt RM, Keshavarzian A (2014) Intestinal CYP2E1: a mediator of alcohol-induced gut leakiness. Redox Biol 3:40\u201346","journal-title":"Redox Biol"},{"issue":"1","key":"5061_CR88","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41572-018-0014-7","volume":"4","author":"HK Seitz","year":"2018","unstructured":"Seitz HK et al (2018) Alcoholic liver disease. Nat Rev Dis Primers 4(1):16","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"5061_CR89","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.jhep.2008.10.028","volume":"50","author":"A Keshavarzian","year":"2009","unstructured":"Keshavarzian A et al (2009) Evidence that chronic alcohol exposure promotes intestinal oxidative stress, intestinal hyperpermeability and endotoxemia prior to development of alcoholic steatohepatitis in rats. J Hepatol 50(3):538\u2013547","journal-title":"J Hepatol"},{"issue":"157","key":"5061_CR90","doi-asserted-by":"publisher","first-page":"200165","DOI":"10.1183\/16000617.0165-2020","volume":"29","author":"SM Cloonan","year":"2020","unstructured":"Cloonan SM et al (2020) Mitochondrial dysfunction in lung ageing and disease. Eur Respir Rev 29(157):200165","journal-title":"Eur Respir Rev"},{"issue":"11","key":"5061_CR91","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1016\/j.bmcl.2019.03.041","volume":"29","author":"M Webb","year":"2019","unstructured":"Webb M, Sideris DP, Biddle M (2019) Modulation of mitochondrial dysfunction for treatment of disease. Bioorg Med Chem Lett 29(11):1270\u20131277","journal-title":"Bioorg Med Chem Lett"},{"issue":"7","key":"5061_CR92","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/s41556-018-0124-1","volume":"20","author":"JB Spinelli","year":"2018","unstructured":"Spinelli JB, Haigis MC (2018) The multifaceted contributions of mitochondria to cellular metabolism. Nat Cell Biol 20(7):745\u2013754","journal-title":"Nat Cell Biol"},{"key":"5061_CR93","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mito.2020.06.008","volume":"54","author":"J Saleh","year":"2020","unstructured":"Saleh J et al (2020) Mitochondria and microbiota dysfunction in COVID-19 pathogenesis. Mitochondrion 54:1\u20137","journal-title":"Mitochondrion"},{"issue":"10","key":"5061_CR94","doi-asserted-by":"publisher","first-page":"8650","DOI":"10.3390\/ijms24108650","volume":"24","author":"RW Siggins","year":"2023","unstructured":"Siggins RW et al (2023) Mitochondrial dysfunction: at the nexus between alcohol-associated immunometabolic dysregulation and tissue injury. Int J Mol Sci 24(10):8650","journal-title":"Int J Mol Sci"},{"key":"5061_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2020.101134","volume":"50","author":"M Shum","year":"2021","unstructured":"Shum M et al (2021) Mitochondrial oxidative function in NAFLD: friend or foe? Mol Metab 50:101134","journal-title":"Mol Metab"},{"issue":"2","key":"5061_CR96","first-page":"74","volume":"13","author":"M Modanloo","year":"2019","unstructured":"Modanloo M, Shokrzadeh M (2019) Analyzing mitochondrial dysfunction, oxidative stress, and apoptosis: potential role of l-carnitine. Iran J Kidney Dis 13(2):74\u201386","journal-title":"Iran J Kidney Dis"},{"issue":"10","key":"5061_CR97","doi-asserted-by":"publisher","first-page":"909","DOI":"10.3390\/antiox9100909","volume":"9","author":"M Mar\u00ed","year":"2020","unstructured":"Mar\u00ed M et al (2020) Mitochondrial glutathione: recent insights and role in disease. Antioxidants (Basel) 9(10):909","journal-title":"Antioxidants (Basel)"},{"key":"5061_CR98","doi-asserted-by":"publisher","first-page":"1452696","DOI":"10.1155\/2020\/1452696","volume":"2020","author":"S Rius-P\u00e9rez","year":"2020","unstructured":"Rius-P\u00e9rez S et al (2020) PGC-1\u03b1, inflammation, and oxidative stress: an integrative view in metabolism. Oxid Med Cell Longev 2020:1452696","journal-title":"Oxid Med Cell Longev"},{"issue":"17","key":"5061_CR99","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1089\/ars.2017.7342","volume":"29","author":"C Tonelli","year":"2018","unstructured":"Tonelli C, Chio IIC, Tuveson DA (2018) Transcriptional regulation by Nrf2. Antioxid Redox Signal 29(17):1727\u20131745","journal-title":"Antioxid Redox Signal"},{"issue":"13","key":"5061_CR100","doi-asserted-by":"publisher","first-page":"4777","DOI":"10.3390\/ijms21134777","volume":"21","author":"F He","year":"2020","unstructured":"He F, Ru X, Wen T (2020) NRF2, a transcription factor for stress response and beyond. Int J Mol Sci 21(13):4777","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5061_CR101","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1089\/dna.2018.4348","volume":"38","author":"P Fan","year":"2019","unstructured":"Fan P et al (2019) Molecular regulation mechanisms and interactions between reactive oxygen species and mitophagy. DNA Cell Biol 38(1):10\u201322","journal-title":"DNA Cell Biol"},{"issue":"2","key":"5061_CR102","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3109\/01480545.2015.1092039","volume":"39","author":"M Ahadpour","year":"2016","unstructured":"Ahadpour M et al (2016) Mitochondrial oxidative stress and dysfunction induced by isoniazid: study on isolated rat liver and brain mitochondria. Drug Chem Toxicol 39(2):224\u2013232","journal-title":"Drug Chem Toxicol"},{"issue":"5","key":"5061_CR103","doi-asserted-by":"publisher","first-page":"434","DOI":"10.2174\/138920110791591436","volume":"11","author":"BJ Song","year":"2010","unstructured":"Song BJ et al (2010) Mechanisms of MDMA (ecstasy)-induced oxidative stress, mitochondrial dysfunction, and organ damage. Curr Pharm Biotechnol 11(5):434\u2013443","journal-title":"Curr Pharm Biotechnol"},{"issue":"11","key":"5061_CR104","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1111\/j.1365-2893.2009.01238.x","volume":"17","author":"T Wang","year":"2010","unstructured":"Wang T et al (2010) Role of hepatitis C virus core protein in viral-induced mitochondrial dysfunction. J Viral Hepat 17(11):784\u2013793","journal-title":"J Viral Hepat"},{"key":"5061_CR105","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2019.117148","volume":"241","author":"H Rizwan","year":"2020","unstructured":"Rizwan H et al (2020) High glucose augments ROS generation regulates mitochondrial dysfunction and apoptosis via stress signalling cascades in keratinocytes. Life Sci 241:117148","journal-title":"Life Sci"},{"issue":"40","key":"5061_CR106","doi-asserted-by":"publisher","first-page":"5597","DOI":"10.2174\/0929867324666170616101741","volume":"25","author":"E Dombi","year":"2018","unstructured":"Dombi E, Mortiboys H, Poulton J (2018) Modulating mitophagy in mitochondrial disease. Curr Med Chem 25(40):5597\u20135612","journal-title":"Curr Med Chem"},{"issue":"2","key":"5061_CR107","doi-asserted-by":"publisher","first-page":"586","DOI":"10.3390\/ijms22020586","volume":"22","author":"M Protasoni","year":"2021","unstructured":"Protasoni M, Zeviani M (2021) Mitochondrial structure and bioenergetics in normal and disease conditions. Int J Mol Sci 22(2):586","journal-title":"Int J Mol Sci"},{"key":"5061_CR108","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.831168","volume":"13","author":"Y Yang","year":"2022","unstructured":"Yang Y et al (2022) Regulation of SIRT1 and its roles in inflammation. Front Immunol 13:831168","journal-title":"Front Immunol"},{"issue":"1","key":"5061_CR109","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3390\/ijms21010265","volume":"21","author":"A Nagappan","year":"2019","unstructured":"Nagappan A et al (2019) Cryptotanshinone from the Salvia miltiorrhiza Bunge attenuates ethanol-induced liver injury by activation of AMPK\/SIRT1 and Nrf2 signaling pathways. Int J Mol Sci 21(1):265","journal-title":"Int J Mol Sci"},{"key":"5061_CR110","doi-asserted-by":"publisher","first-page":"453","DOI":"10.3389\/fphar.2018.00453","volume":"9","author":"A Moles","year":"2018","unstructured":"Moles A et al (2018) Mitochondrial-lysosomal axis in acetaminophen hepatotoxicity. Front Pharmacol 9:453","journal-title":"Front Pharmacol"},{"issue":"5\u20136","key":"5061_CR111","doi-asserted-by":"publisher","DOI":"10.1002\/pmic.201800404","volume":"20","author":"V Natarajan","year":"2020","unstructured":"Natarajan V et al (2020) Mitochondrial dysfunction in age-related metabolic disorders. Proteomics 20(5\u20136):e1800404","journal-title":"Proteomics"},{"issue":"2","key":"5061_CR112","first-page":"205","volume":"12","author":"S Nesci","year":"2022","unstructured":"Nesci S, Lenaz G (2022) Impaired mitochondrial bioenergetics under pathological conditions. Life (Basel) 12(2):205","journal-title":"Life (Basel)"},{"issue":"1\u20132","key":"5061_CR113","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0005-2728(98)00120-0","volume":"1366","author":"G Lenaz","year":"1998","unstructured":"Lenaz G (1998) Role of mitochondria in oxidative stress and ageing. Biochim Biophys Acta 1366(1\u20132):53\u201367","journal-title":"Biochim Biophys Acta"},{"key":"5061_CR114","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.120838","volume":"306","author":"Z Junli","year":"2022","unstructured":"Junli Z et al (2022) The role and mechanism of CREBH regulating SIRT3 in metabolic associated fatty liver disease. Life Sci 306:120838","journal-title":"Life Sci"},{"key":"5061_CR115","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.redox.2018.07.011","volume":"18","author":"R Li","year":"2018","unstructured":"Li R et al (2018) Therapeutic effect of Sirtuin 3 on ameliorating nonalcoholic fatty liver disease: the role of the ERK-CREB pathway and Bnip3-mediated mitophagy. Redox Biol 18:229\u2013243","journal-title":"Redox Biol"},{"issue":"18","key":"5061_CR116","doi-asserted-by":"publisher","first-page":"4166","DOI":"10.1111\/bph.15159","volume":"177","author":"R Sun","year":"2020","unstructured":"Sun R et al (2020) Sirtuin 3-mediated deacetylation of acyl-CoA synthetase family member 3 by protocatechuic acid attenuates non-alcoholic fatty liver disease. Br J Pharmacol 177(18):4166\u20134180","journal-title":"Br J Pharmacol"},{"issue":"4","key":"5061_CR117","first-page":"410","volume":"44","author":"T Wu","year":"2014","unstructured":"Wu T et al (2014) Direct evidence of sirtuin downregulation in the liver of non-alcoholic fatty liver disease patients. Ann Clin Lab Sci 44(4):410\u2013418","journal-title":"Ann Clin Lab Sci"},{"issue":"5","key":"5061_CR118","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.3390\/cells9051101","volume":"9","author":"A Kundu","year":"2020","unstructured":"Kundu A et al (2020) EX-527 prevents the progression of high-fat diet-induced hepatic steatosis and fibrosis by upregulating SIRT4 in Zucker rats. Cells 9(5):1101","journal-title":"Cells"},{"issue":"1","key":"5061_CR119","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1186\/s13046-019-1456-9","volume":"38","author":"Z Li","year":"2019","unstructured":"Li Z et al (2019) SIRT4 silencing in tumor-associated macrophages promotes HCC development via PPAR\u03b4 signalling-mediated alternative activation of macrophages. J Exp Clin Cancer Res 38(1):469","journal-title":"J Exp Clin Cancer Res"},{"issue":"4","key":"5061_CR120","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1002\/hep.30421","volume":"69","author":"YS Wang","year":"2019","unstructured":"Wang YS et al (2019) Sirtuin 4 depletion promotes hepatocellular carcinoma tumorigenesis through regulating adenosine-monophosphate-activated protein kinase alpha\/mammalian target of rapamycin axis in mice. Hepatology 69(4):1614\u20131631","journal-title":"Hepatology"},{"issue":"11","key":"5061_CR121","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1038\/s41419-022-05409-0","volume":"13","author":"X Yin","year":"2022","unstructured":"Yin X et al (2022) Targeting glutamine metabolism in hepatic stellate cells alleviates liver fibrosis. Cell Death Dis 13(11):955","journal-title":"Cell Death Dis"},{"issue":"12","key":"5061_CR122","first-page":"2453","volume":"8","author":"D Guo","year":"2018","unstructured":"Guo D et al (2018) Vimentin acetylation is involved in SIRT5-mediated hepatocellular carcinoma migration. Am J Cancer Res 8(12):2453\u20132466","journal-title":"Am J Cancer Res"},{"issue":"4","key":"5061_CR123","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.molmed.2017.02.005","volume":"23","author":"RAH van de Ven","year":"2017","unstructured":"van de Ven RAH, Santos D, Haigis MC (2017) Mitochondrial sirtuins and molecular mechanisms of aging. Trends Mol Med 23(4):320\u2013331","journal-title":"Trends Mol Med"},{"issue":"2","key":"5061_CR124","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.bbrc.2008.06.006","volume":"373","author":"CS Lieber","year":"2008","unstructured":"Lieber CS et al (2008) Alcohol alters hepatic FoxO1, p53, and mitochondrial SIRT5 deacetylation function. Biochem Biophys Res Commun 373(2):246\u2013252","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"5061_CR125","first-page":"88","volume":"4","author":"M You","year":"2015","unstructured":"You M et al (2015) Sirtuin 1 signaling and alcoholic fatty liver disease. Hepatobil Surg Nutr 4(2):88\u2013100","journal-title":"Hepatobil Surg Nutr"},{"key":"5061_CR126","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jnutbio.2017.11.011","volume":"55","author":"Y Choi","year":"2018","unstructured":"Choi Y, Abdelmegeed MA, Song BJ (2018) Preventive effects of indole-3-carbinol against alcohol-induced liver injury in mice via antioxidant, anti-inflammatory, and anti-apoptotic mechanisms: role of gut\u2013liver-adipose tissue axis. J Nutr Biochem 55:12\u201325","journal-title":"J Nutr Biochem"},{"issue":"1","key":"5061_CR127","doi-asserted-by":"publisher","first-page":"272","DOI":"10.3390\/molecules28010272","volume":"28","author":"P Yao","year":"2022","unstructured":"Yao P, Liu Y (2022) Terpenoids: natural compounds for non-alcoholic fatty liver disease (NAFLD) therapy. Molecules 28(1):272","journal-title":"Molecules"},{"key":"5061_CR128","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.freeradbiomed.2016.04.197","volume":"100","author":"B Osborne","year":"2016","unstructured":"Osborne B et al (2016) The role of mitochondrial sirtuins in health and disease. Free Radic Biol Med 100:164\u2013174","journal-title":"Free Radic Biol Med"},{"key":"5061_CR129","doi-asserted-by":"crossref","unstructured":"Goikoetxea-Usandizaga N et al (2023) The outcome of boosting mitochondrial activity in alcohol-associated liver disease is organ-dependent. Hepatology 78(3):878-895","DOI":"10.1097\/HEP.0000000000000303"},{"issue":"3","key":"5061_CR130","doi-asserted-by":"publisher","DOI":"10.1111\/jpi.12638","volume":"68","author":"SE Lee","year":"2020","unstructured":"Lee SE et al (2020) Induction of SIRT1 by melatonin improves alcohol-mediated oxidative liver injury by disrupting the CRBN-YY1-CYP2E1 signaling pathway. J Pineal Res 68(3):e12638","journal-title":"J Pineal Res"},{"issue":"3","key":"5061_CR131","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.yexmp.2008.08.002","volume":"85","author":"J Oliva","year":"2008","unstructured":"Oliva J et al (2008) Sirt1 is involved in energy metabolism: the role of chronic ethanol feeding and resveratrol. Exp Mol Pathol 85(3):155\u2013159","journal-title":"Exp Mol Pathol"},{"key":"5061_CR132","first-page":"1649","volume":"10","author":"J Zhu","year":"2016","unstructured":"Zhu J et al (2016) The combination of blueberry juice and probiotics reduces apoptosis of alcoholic fatty liver of mice by affecting SIRT1 pathway. Drug Des Dev Ther 10:1649\u20131661","journal-title":"Drug Des Dev Ther"},{"issue":"7","key":"5061_CR133","doi-asserted-by":"publisher","first-page":"852","DOI":"10.7150\/ijbs.19370","volume":"13","author":"RB Ding","year":"2017","unstructured":"Ding RB, Bao J, Deng CX (2017) Emerging roles of SIRT1 in fatty liver diseases. Int J Biol Sci 13(7):852\u2013867","journal-title":"Int J Biol Sci"},{"issue":"11","key":"5061_CR134","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.2337\/db07-0156","volume":"56","author":"J Westerbacka","year":"2007","unstructured":"Westerbacka J et al (2007) Genes involved in fatty acid partitioning and binding, lipolysis, monocyte\/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects. Diabetes 56(11):2759\u20132765","journal-title":"Diabetes"},{"issue":"6478","key":"5061_CR135","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1126\/science.aay0542","volume":"367","author":"P Zhao","year":"2020","unstructured":"Zhao P et al (2020) An AMPK-caspase-6 axis controls liver damage in nonalcoholic steatohepatitis. Science 367(6478):652\u2013660","journal-title":"Science"},{"key":"5061_CR136","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2021.153739","volume":"92","author":"R Huang","year":"2021","unstructured":"Huang R et al (2021) Activation of AMPK by triptolide alleviates nonalcoholic fatty liver disease by improving hepatic lipid metabolism, inflammation and fibrosis. Phytomedicine 92:153739","journal-title":"Phytomedicine"},{"issue":"1","key":"5061_CR137","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jphs.2022.01.012","volume":"149","author":"Q Xiao","year":"2022","unstructured":"Xiao Q et al (2022) Orientin reverses acetaminophen-induced acute liver failure by inhibiting oxidative stress and mitochondrial dysfunction. J Pharmacol Sci 149(1):11\u201319","journal-title":"J Pharmacol Sci"},{"issue":"1","key":"5061_CR138","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3390\/nu15010174","volume":"15","author":"W Li","year":"2022","unstructured":"Li W et al (2022) NAD supplement alleviates intestinal barrier injury induced by ethanol via protecting epithelial mitochondrial function. Nutrients 15(1):174","journal-title":"Nutrients"},{"issue":"9","key":"5061_CR139","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1038\/s41374-021-00599-1","volume":"101","author":"H Kang","year":"2021","unstructured":"Kang H, Park YK, Lee JY (2021) Nicotinamide riboside, an NAD(+) precursor, attenuates inflammation and oxidative stress by activating sirtuin 1 in alcohol-stimulated macrophages. Lab Invest 101(9):1225\u20131237","journal-title":"Lab Invest"},{"issue":"3","key":"5061_CR140","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e14205","volume":"9","author":"A Ghorbanpour","year":"2023","unstructured":"Ghorbanpour A et al (2023) Capsaicin protects against septic acute liver injury by attenuation of apoptosis and mitochondrial dysfunction. Heliyon 9(3):e14205","journal-title":"Heliyon"},{"key":"5061_CR141","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.redox.2018.04.019","volume":"17","author":"M Yan","year":"2018","unstructured":"Yan M et al (2018) Mechanisms of acetaminophen-induced liver injury and its implications for therapeutic interventions. Redox Biol 17:274\u2013283","journal-title":"Redox Biol"},{"issue":"Suppl 6","key":"5061_CR142","doi-asserted-by":"publisher","first-page":"s104","DOI":"10.7861\/clinmedicine.16-6-s104","volume":"16","author":"D Katarey","year":"2016","unstructured":"Katarey D, Verma S (2016) Drug-induced liver injury. Clin Med (Lond) 16(Suppl 6):s104\u2013s109","journal-title":"Clin Med (Lond)"},{"issue":"5","key":"5061_CR143","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1136\/gutjnl-2020-320786","volume":"70","author":"TH Tranah","year":"2021","unstructured":"Tranah TH et al (2021) Targeting the gut\u2013liver-immune axis to treat cirrhosis. Gut 70(5):982\u2013994","journal-title":"Gut"},{"issue":"24","key":"5061_CR144","doi-asserted-by":"publisher","first-page":"4038","DOI":"10.3390\/cells11244038","volume":"11","author":"M Kalyan","year":"2022","unstructured":"Kalyan M et al (2022) Role of endogenous lipopolysaccharides in neurological disorders. Cells 11(24):4038","journal-title":"Cells"},{"key":"5061_CR145","doi-asserted-by":"crossref","unstructured":"Konturek PC et al (2018) Gut\u2013liver axis: how do gut bacteria influence the liver? Med Sci (Basel) 6(3):79","DOI":"10.3390\/medsci6030079"},{"issue":"7","key":"5061_CR146","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1053\/j.gastro.2017.01.055","volume":"152","author":"O Ch\u00e1vez-Talavera","year":"2017","unstructured":"Ch\u00e1vez-Talavera O et al (2017) Bile acid control of metabolism and inflammation in obesity, type 2 diabetes, dyslipidemia, and nonalcoholic fatty liver disease. Gastroenterology 152(7):1679-1694.e3","journal-title":"Gastroenterology"},{"issue":"7","key":"5061_CR147","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/s41575-018-0011-z","volume":"15","author":"A Tripathi","year":"2018","unstructured":"Tripathi A et al (2018) The gut\u2013liver axis and the intersection with the microbiome. Nat Rev Gastroenterol Hepatol 15(7):397\u2013411","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"7919","key":"5061_CR148","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/s41586-022-04949-x","volume":"607","author":"Y Yang","year":"2022","unstructured":"Yang Y et al (2022) Within-host evolution of a gut pathobiont facilitates liver translocation. Nature 607(7919):563\u2013570","journal-title":"Nature"},{"issue":"4","key":"5061_CR149","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1053\/j.gastro.2011.06.063","volume":"141","author":"NG Sandler","year":"2011","unstructured":"Sandler NG et al (2011) Host response to translocated microbial products predicts outcomes of patients with HBV or HCV infection. Gastroenterology 141(4):1220\u20131230","journal-title":"Gastroenterology"},{"issue":"8","key":"5061_CR150","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.3390\/nu11081712","volume":"11","author":"Y Ji","year":"2019","unstructured":"Ji Y et al (2019) Gut microbiota-derived components and metabolites in the progression of non-alcoholic fatty liver disease (NAFLD). Nutrients 11(8):1712","journal-title":"Nutrients"},{"key":"5061_CR151","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.redox.2018.01.009","volume":"15","author":"A Borrelli","year":"2018","unstructured":"Borrelli A et al (2018) Role of gut microbiota and oxidative stress in the progression of non-alcoholic fatty liver disease to hepatocarcinoma: current and innovative therapeutic approaches. Redox Biol 15:467\u2013479","journal-title":"Redox Biol"},{"issue":"3","key":"5061_CR152","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","volume":"72","author":"A Albillos","year":"2020","unstructured":"Albillos A, de Gottardi A, Rescigno M (2020) The gut\u2013liver axis in liver disease: pathophysiological basis for therapy. J Hepatol 72(3):558\u2013577","journal-title":"J Hepatol"},{"issue":"5","key":"5061_CR153","doi-asserted-by":"publisher","first-page":"666","DOI":"10.5009\/gnl20032","volume":"15","author":"H Fukui","year":"2021","unstructured":"Fukui H (2021) Leaky gut and gut\u2013liver axis in liver cirrhosis: clinical studies update. Gut Liver 15(5):666\u2013676","journal-title":"Gut Liver"},{"issue":"2","key":"5061_CR154","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3350\/cmh.2017.0067","volume":"24","author":"AM Cassard","year":"2018","unstructured":"Cassard AM, Ciocan D (2018) Microbiota, a key player in alcoholic liver disease. Clin Mol Hepatol 24(2):100\u2013107","journal-title":"Clin Mol Hepatol"},{"issue":"1","key":"5061_CR155","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s40168-017-0359-2","volume":"5","author":"VB Dubinkina","year":"2017","unstructured":"Dubinkina VB et al (2017) Links of gut microbiota composition with alcohol dependence syndrome and alcoholic liver disease. Microbiome 5(1):141","journal-title":"Microbiome"},{"issue":"2","key":"5061_CR156","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1002\/hep.24423","volume":"54","author":"Y Chen","year":"2011","unstructured":"Chen Y et al (2011) Characterization of fecal microbial communities in patients with liver cirrhosis. Hepatology 54(2):562\u2013572","journal-title":"Hepatology"},{"issue":"5","key":"5061_CR157","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.jhep.2013.12.019","volume":"60","author":"JS Bajaj","year":"2014","unstructured":"Bajaj JS et al (2014) Altered profile of human gut microbiome is associated with cirrhosis and its complications. J Hepatol 60(5):940\u2013947","journal-title":"J Hepatol"},{"issue":"1","key":"5061_CR158","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13568-023-01539-6","volume":"13","author":"H Zhang","year":"2023","unstructured":"Zhang H et al (2023) Identification reproducible microbiota biomarkers for the diagnosis of cirrhosis and hepatocellular carcinoma. AMB Express 13(1):35","journal-title":"AMB Express"},{"issue":"7516","key":"5061_CR159","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nature13568","volume":"513","author":"N Qin","year":"2014","unstructured":"Qin N et al (2014) Alterations of the human gut microbiome in liver cirrhosis. Nature 513(7516):59\u201364","journal-title":"Nature"},{"issue":"2","key":"5061_CR160","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1002\/hep.26093","volume":"57","author":"L Zhu","year":"2013","unstructured":"Zhu L et al (2013) Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH. Hepatology 57(2):601\u2013609","journal-title":"Hepatology"},{"issue":"9","key":"5061_CR161","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.3390\/nu14091773","volume":"14","author":"FM Calabrese","year":"2022","unstructured":"Calabrese FM et al (2022) A low glycemic index mediterranean diet combined with aerobic physical activity rearranges the gut microbiota signature in NAFLD patients. Nutrients 14(9):1773","journal-title":"Nutrients"},{"key":"5061_CR162","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.3389\/fmicb.2017.02222","volume":"8","author":"J Wang","year":"2017","unstructured":"Wang J et al (2017) Gut microbial dysbiosis is associated with altered hepatic functions and serum metabolites in chronic hepatitis B patients. Front Microbiol 8:2222","journal-title":"Front Microbiol"},{"key":"5061_CR163","doi-asserted-by":"publisher","first-page":"2361963","DOI":"10.1155\/2018\/2361963","volume":"2018","author":"R Yang","year":"2018","unstructured":"Yang R et al (2018) The immunologic role of gut microbiota in patients with chronic HBV infection. J Immunol Res 2018:2361963","journal-title":"J Immunol Res"},{"issue":"4","key":"5061_CR164","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.jhin.2017.04.007","volume":"96","author":"Y Kang","year":"2017","unstructured":"Kang Y, Cai Y (2017) Gut microbiota and hepatitis-B-virus-induced chronic liver disease: implications for faecal microbiota transplantation therapy. J Hosp Infect 96(4):342\u2013348","journal-title":"J Hosp Infect"},{"issue":"5","key":"5061_CR165","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1002\/hep.29008","volume":"65","author":"YD Ren","year":"2017","unstructured":"Ren YD et al (2017) Fecal microbiota transplantation induces hepatitis B virus e-antigen (HBeAg) clearance in patients with positive HBeAg after long-term antiviral therapy. Hepatology 65(5):1765\u20131768","journal-title":"Hepatology"},{"issue":"1","key":"5061_CR166","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13099-016-0124-2","volume":"8","author":"AM Aly","year":"2016","unstructured":"Aly AM et al (2016) Gut microbiome alterations in patients with stage 4 hepatitis C. Gut Pathog 8(1):42","journal-title":"Gut Pathog"},{"issue":"9","key":"5061_CR167","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1080\/17474124.2017.1343663","volume":"11","author":"T Preveden","year":"2017","unstructured":"Preveden T et al (2017) Gut microbiota changes and chronic hepatitis C virus infection. Expert Rev Gastroenterol Hepatol 11(9):813\u2013819","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"1","key":"5061_CR168","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/liv.13485","volume":"38","author":"B Heidrich","year":"2018","unstructured":"Heidrich B et al (2018) Intestinal microbiota in patients with chronic hepatitis C with and without cirrhosis compared with healthy controls. Liver Int 38(1):50\u201358","journal-title":"Liver Int"},{"issue":"5","key":"5061_CR169","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1016\/j.transproceed.2016.01.077","volume":"48","author":"M Gr\u0105t","year":"2016","unstructured":"Gr\u0105t M et al (2016) Profile of gut microbiota associated with the presence of hepatocellular cancer in patients with liver cirrhosis. Transplant Proc 48(5):1687\u20131691","journal-title":"Transplant Proc"},{"key":"5061_CR170","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1146\/annurev-genom-090711-163814","volume":"13","author":"EA Grice","year":"2012","unstructured":"Grice EA, Segre JA (2012) The human microbiome: our second genome. Annu Rev Genomics Hum Genet 13:151\u2013170","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"5061_CR171","doi-asserted-by":"crossref","unstructured":"(2012) Structure, function and diversity of the healthy human microbiome. Nature. 486(7402):207\u2013214","DOI":"10.1038\/nature11234"},{"issue":"8","key":"5061_CR172","doi-asserted-by":"publisher","first-page":"270","DOI":"10.3390\/antiox8080270","volume":"8","author":"HM Wang","year":"2019","unstructured":"Wang HM et al (2019) Inhibition of LPS-induced oxidative damages and potential anti-inflammatory effects of phyllanthus emblica extract via down-regulating NF-\u03baB, COX-2, and iNOS in RAW 264.7 cells. Antioxidants (Basel) 8(8):270","journal-title":"Antioxidants (Basel)"},{"issue":"9","key":"5061_CR173","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.3390\/antiox10091386","volume":"10","author":"DH Kim","year":"2021","unstructured":"Kim DH et al (2021) Ellagic Acid prevents binge alcohol-induced leaky gut and liver injury through inhibiting gut dysbiosis and oxidative stress. Antioxidants (Basel) 10(9):1386","journal-title":"Antioxidants (Basel)"},{"issue":"6","key":"5061_CR174","doi-asserted-by":"publisher","first-page":"514","DOI":"10.3390\/metabo12060514","volume":"12","author":"C Teunis","year":"2022","unstructured":"Teunis C, Nieuwdorp M, Hanssen N (2022) Interactions between tryptophan metabolism, the gut microbiome and the immune system as potential drivers of non-alcoholic fatty liver disease (NAFLD) and metabolic diseases. Metabolites 12(6):514","journal-title":"Metabolites"},{"issue":"1","key":"5061_CR175","doi-asserted-by":"publisher","first-page":"8742","DOI":"10.1038\/s41598-019-45009-1","volume":"9","author":"S Sarkar","year":"2019","unstructured":"Sarkar S et al (2019) Environmental microcystin targets the microbiome and increases the risk of intestinal inflammatory pathology via NOX2 in underlying murine model of nonalcoholic fatty liver disease. Sci Rep 9(1):8742","journal-title":"Sci Rep"},{"key":"5061_CR176","doi-asserted-by":"crossref","unstructured":"Peiseler M et al (2022) Immune mechanisms linking metabolic injury to inflammation and fibrosis in fatty liver disease\u2014novel insights into cellular communication circuits. J Hepatol","DOI":"10.1016\/j.jhep.2022.06.012"},{"key":"5061_CR177","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.595371","volume":"8","author":"AP Delli Bovi","year":"2021","unstructured":"Delli Bovi AP et al (2021) Oxidative stress in non-alcoholic fatty liver disease. An updated mini review. Front Med (Lausanne) 8:595371","journal-title":"Front Med (Lausanne)"},{"issue":"5","key":"5061_CR178","doi-asserted-by":"publisher","first-page":"E532","DOI":"10.1152\/ajpendo.00258.2011","volume":"302","author":"H Zong","year":"2012","unstructured":"Zong H et al (2012) Cytochrome P-450 CYP2E1 knockout mice are protected against high-fat diet-induced obesity and insulin resistance. Am J Physiol Endocrinol Metab 302(5):E532\u2013E539","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"6","key":"5061_CR179","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1053\/gast.2002.33573","volume":"122","author":"JM Clark","year":"2002","unstructured":"Clark JM, Brancati FL, Diehl AM (2002) Nonalcoholic fatty liver disease. Gastroenterology 122(6):1649\u20131657","journal-title":"Gastroenterology"},{"issue":"9","key":"5061_CR180","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1136\/gutjnl-2014-308379","volume":"65","author":"AJ Engstler","year":"2016","unstructured":"Engstler AJ et al (2016) Insulin resistance alters hepatic ethanol metabolism: studies in mice and children with non-alcoholic fatty liver disease. Gut 65(9):1564\u20131571","journal-title":"Gut"},{"issue":"4","key":"5061_CR181","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.jhep.2020.01.013","volume":"72","author":"CD Byrne","year":"2020","unstructured":"Byrne CD, Targher G (2020) NAFLD as a driver of chronic kidney disease. J Hepatol 72(4):785\u2013801","journal-title":"J Hepatol"},{"issue":"6","key":"5061_CR182","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1136\/gutjnl-2017-313884","volume":"66","author":"LA Adams","year":"2017","unstructured":"Adams LA et al (2017) Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases. Gut 66(6):1138\u20131153","journal-title":"Gut"},{"issue":"1","key":"5061_CR183","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3390\/nu14010103","volume":"14","author":"K Dro\u017cd\u017c","year":"2021","unstructured":"Dro\u017cd\u017c K et al (2021) Metabolic-associated fatty liver disease (MAFLD), diabetes, and cardiovascular disease: associations with fructose metabolism and gut microbiota. Nutrients 14(1):103","journal-title":"Nutrients"},{"issue":"9","key":"5061_CR184","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.7150\/ijbs.21047","volume":"13","author":"C Mandal","year":"2017","unstructured":"Mandal C et al (2017) In utero alcohol exposure and the alteration of histone marks in the developing fetus: an epigenetic phenomenon of maternal drinking. Int J Biol Sci 13(9):1100\u20131108","journal-title":"Int J Biol Sci"},{"issue":"4","key":"5061_CR185","first-page":"245","volume":"29","author":"S Zakhari","year":"2006","unstructured":"Zakhari S (2006) Overview: how is alcohol metabolized by the body? Alcohol Res Health 29(4):245\u2013254","journal-title":"Alcohol Res Health"},{"issue":"2","key":"5061_CR186","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s12276-021-00561-7","volume":"53","author":"W Rungratanawanich","year":"2021","unstructured":"Rungratanawanich W et al (2021) Advanced glycation end products (AGEs) and other adducts in aging-related diseases and alcohol-mediated tissue injury. Exp Mol Med 53(2):168\u2013188","journal-title":"Exp Mol Med"},{"issue":"4","key":"5061_CR187","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.cld.2012.08.002","volume":"16","author":"AI Cederbaum","year":"2012","unstructured":"Cederbaum AI (2012) Alcohol metabolism. Clin Liver Dis 16(4):667\u2013685","journal-title":"Clin Liver Dis"},{"issue":"5\u20136","key":"5061_CR188","first-page":"265","volume":"74","author":"N Paquot","year":"2019","unstructured":"Paquot N (2019) The metabolism of alcohol. Rev Med Liege 74(5\u20136):265\u2013267","journal-title":"Rev Med Liege"},{"issue":"15","key":"5061_CR189","doi-asserted-by":"publisher","first-page":"8221","DOI":"10.3390\/ijms22158221","volume":"22","author":"R Harjum\u00e4ki","year":"2021","unstructured":"Harjum\u00e4ki R, Pridgeon CS, Ingelman-Sundberg M (2021) CYP2E1 in alcoholic and non-alcoholic liver injury. Roles of ROS, reactive intermediates and lipid overload. Int J Mol Sci 22(15):8221","journal-title":"Int J Mol Sci"},{"key":"5061_CR190","doi-asserted-by":"publisher","first-page":"119328","DOI":"10.1016\/j.lfs.2021.119328","volume":"274","author":"A Namachivayam","year":"2021","unstructured":"Namachivayam A, Valsala Gopalakrishnan A (2021) A review on molecular mechanism of alcoholic liver disease. Life Sci 274:119328","journal-title":"Life Sci"},{"issue":"2","key":"5061_CR191","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1080\/03602532.2019.1632889","volume":"51","author":"J Chen","year":"2019","unstructured":"Chen J et al (2019) A comprehensive review of cytochrome P450 2E1 for xenobiotic metabolism. Drug Metab Rev 51(2):178\u2013195","journal-title":"Drug Metab Rev"},{"key":"5061_CR192","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2019.108918","volume":"316","author":"HK Seitz","year":"2020","unstructured":"Seitz HK (2020) The role of cytochrome P4502E1 in the pathogenesis of alcoholic liver disease and carcinogenesis. Chem Biol Interact 316:108918","journal-title":"Chem Biol Interact"},{"issue":"4","key":"5061_CR193","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.jcmgh.2015.05.006","volume":"1","author":"S Joshi-Barve","year":"2015","unstructured":"Joshi-Barve S et al (2015) Alcoholic, nonalcoholic, and toxicant-associated steatohepatitis: mechanistic similarities and differences. Cell Mol Gastroenterol Hepatol 1(4):356\u2013367","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"2","key":"5061_CR194","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1002\/hep.20532","volume":"41","author":"BU Bradford","year":"2005","unstructured":"Bradford BU et al (2005) Cytochrome P450 CYP2E1, but not nicotinamide adenine dinucleotide phosphate oxidase, is required for ethanol-induced oxidative DNA damage in rodent liver. Hepatology 41(2):336\u2013344","journal-title":"Hepatology"},{"issue":"2","key":"5061_CR195","first-page":"147","volume":"38","author":"NA Osna","year":"2017","unstructured":"Osna NA, Donohue TM Jr, Kharbanda KK (2017) Alcoholic liver disease: pathogenesis and current management. Alcohol Res 38(2):147\u2013161","journal-title":"Alcohol Res"},{"issue":"1","key":"5061_CR196","first-page":"84","volume":"67","author":"CS Lieber","year":"2000","unstructured":"Lieber CS (2000) Alcohol and the liver: metabolism of alcohol and its role in hepatic and extrahepatic diseases. Mt Sinai J Med 67(1):84\u201394","journal-title":"Mt Sinai J Med"},{"issue":"3","key":"5061_CR197","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.freeradbiomed.2009.11.008","volume":"48","author":"KH Moon","year":"2010","unstructured":"Moon KH, Lee YM, Song BJ (2010) Inhibition of hepatic mitochondrial aldehyde dehydrogenase by carbon tetrachloride through JNK-mediated phosphorylation. Free Radic Biol Med 48(3):391\u2013398","journal-title":"Free Radic Biol Med"},{"issue":"18","key":"5061_CR198","doi-asserted-by":"publisher","first-page":"3906","DOI":"10.1002\/pmic.200800215","volume":"8","author":"KH Moon","year":"2008","unstructured":"Moon KH et al (2008) Mechanism of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)-mediated mitochondrial dysfunction in rat liver. Proteomics 8(18):3906\u20133918","journal-title":"Proteomics"},{"issue":"1","key":"5061_CR199","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1021\/tx0501839","volume":"19","author":"JA Doorn","year":"2006","unstructured":"Doorn JA, Hurley TD, Petersen DR (2006) Inhibition of human mitochondrial aldehyde dehydrogenase by 4-hydroxynon-2-enal and 4-oxonon-2-enal. Chem Res Toxicol 19(1):102\u2013110","journal-title":"Chem Res Toxicol"},{"issue":"8","key":"5061_CR200","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1111\/acer.12777","volume":"39","author":"KK Chaudhry","year":"2015","unstructured":"Chaudhry KK et al (2015) ALDH2 deficiency promotes ethanol-induced gut barrier dysfunction and fatty liver in mice. Alcohol Clin Exp Res 39(8):1465\u20131475","journal-title":"Alcohol Clin Exp Res"},{"issue":"4","key":"5061_CR201","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1007\/s00204-004-0630-8","volume":"79","author":"YD Kim","year":"2005","unstructured":"Kim YD et al (2005) Expression levels of hepatic cytochrome P450 enzymes in Aldh2-deficient mice following ethanol exposure: a pilot study. Arch Toxicol 79(4):192\u2013195","journal-title":"Arch Toxicol"},{"issue":"2","key":"5061_CR202","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1006\/bbrc.1994.2774","volume":"205","author":"BJ Roberts","year":"1994","unstructured":"Roberts BJ et al (1994) Induction of CYP2E1 in liver, kidney, brain and intestine during chronic ethanol administration and withdrawal: evidence that CYP2E1 possesses a rapid phase half-life of 6 hours or less. Biochem Biophys Res Commun 205(2):1064\u20131071","journal-title":"Biochem Biophys Res Commun"},{"key":"5061_CR203","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/582790","volume":"2012","author":"AI Cederbaum","year":"2012","unstructured":"Cederbaum AI et al (2012) CYP2E1 sensitizes the liver to LPS- and TNF \u03b1-induced toxicity via elevated oxidative and nitrosative stress and activation of ASK-1 and JNK mitogen-activated kinases. Int J Hepatol 2012:582790","journal-title":"Int J Hepatol"},{"issue":"6","key":"5061_CR204","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1159\/000324289","volume":"28","author":"AI Cederbaum","year":"2010","unstructured":"Cederbaum AI (2010) Role of CYP2E1 in ethanol-induced oxidant stress, fatty liver and hepatotoxicity. Dig Dis 28(6):802\u2013811","journal-title":"Dig Dis"},{"issue":"5","key":"5061_CR205","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1002\/hep.22222","volume":"47","author":"Y Lu","year":"2008","unstructured":"Lu Y et al (2008) Cytochrome P450 2E1 contributes to ethanol-induced fatty liver in mice. Hepatology 47(5):1483\u20131494","journal-title":"Hepatology"},{"issue":"3","key":"5061_CR206","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.jhep.2008.10.020","volume":"50","author":"A Butura","year":"2009","unstructured":"Butura A et al (2009) The impact of CYP2E1 on the development of alcoholic liver disease as studied in a transgenic mouse model. J Hepatol 50(3):572\u2013583","journal-title":"J Hepatol"},{"issue":"1","key":"5061_CR207","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/j.1530-0277.1999.tb04028.x","volume":"23","author":"MK Aleynik","year":"1999","unstructured":"Aleynik MK et al (1999) Polyenylphosphatidylcholine opposes the increase of cytochrome P-4502E1 by ethanol and corrects its iron-induced decrease. Alcohol Clin Exp Res 23(1):96\u2013100","journal-title":"Alcohol Clin Exp Res"},{"issue":"1","key":"5061_CR208","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1053\/jhep.2002.33720","volume":"36","author":"K Morgan","year":"2002","unstructured":"Morgan K, French SW, Morgan TR (2002) Production of a cytochrome P450 2E1 transgenic mouse and initial evaluation of alcoholic liver damage. Hepatology 36(1):122\u2013134","journal-title":"Hepatology"},{"issue":"9","key":"5061_CR209","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1097\/MEG.0b013e328328f461","volume":"21","author":"E Kathirvel","year":"2009","unstructured":"Kathirvel E et al (2009) Overexpression of liver-specific cytochrome P4502E1 impairs hepatic insulin signaling in a transgenic mouse model of nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol 21(9):973\u2013983","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"6","key":"5061_CR210","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1111\/j.1440-1746.2009.06196.x","volume":"25","author":"E Kathirvel","year":"2010","unstructured":"Kathirvel E et al (2010) Oxidative stress and regulation of anti-oxidant enzymes in cytochrome P4502E1 transgenic mouse model of non-alcoholic fatty liver. J Gastroenterol Hepatol 25(6):1136\u20131143","journal-title":"J Gastroenterol Hepatol"},{"issue":"2","key":"5061_CR211","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.jhep.2008.04.023","volume":"49","author":"BJ Song","year":"2008","unstructured":"Song BJ et al (2008) Prevention of alcoholic fatty liver and mitochondrial dysfunction in the rat by long-chain polyunsaturated fatty acids. J Hepatol 49(2):262\u2013273","journal-title":"J Hepatol"},{"issue":"2","key":"5061_CR212","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1093\/alcalc\/agac068","volume":"58","author":"N Hohmann","year":"2023","unstructured":"Hohmann N et al (2023) Effect of clomethiazole vs. clorazepate on hepatic fat and serum transaminase activities in alcohol-associated liver disease: results from a randomized, controlled phase II clinical trial. Alcohol Alcohol 58(2):134\u2013141","journal-title":"Alcohol Alcohol"},{"issue":"14","key":"5061_CR213","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.2174\/1381612824666180410091511","volume":"24","author":"Y Lu","year":"2018","unstructured":"Lu Y, Cederbaum AI (2018) Cytochrome P450s and alcoholic liver disease. Curr Pharm Des 24(14):1502\u20131517","journal-title":"Curr Pharm Des"},{"issue":"2","key":"5061_CR214","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/j.1530-0277.2008.00827.x","volume":"33","author":"V Purohit","year":"2009","unstructured":"Purohit V, Gao B, Song BJ (2009) Molecular mechanisms of alcoholic fatty liver. Alcohol Clin Exp Res 33(2):191\u2013205","journal-title":"Alcohol Clin Exp Res"},{"issue":"10","key":"5061_CR215","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1111\/acer.14698","volume":"45","author":"T Gopal","year":"2021","unstructured":"Gopal T et al (2021) A review of the role of ethanol-induced adipose tissue dysfunction in alcohol-associated liver disease. Alcohol Clin Exp Res 45(10):1927\u20131939","journal-title":"Alcohol Clin Exp Res"},{"issue":"4","key":"5061_CR216","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.jceh.2017.09.004","volume":"7","author":"A Naim","year":"2017","unstructured":"Naim A, Pan Q, Baig MS (2017) Matrix metalloproteinases (MMPs) in liver diseases. J Clin Exp Hepatol 7(4):367\u2013372","journal-title":"J Clin Exp Hepatol"},{"issue":"6","key":"5061_CR217","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1002\/hep.510230636","volume":"23","author":"LJ Born","year":"1996","unstructured":"Born LJ et al (1996) Effects of ethanol administration on components of the ubiquitin proteolytic pathway in rat liver. Hepatology 23(6):1556\u20131563","journal-title":"Hepatology"},{"issue":"6","key":"5061_CR218","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1002\/hep.30093","volume":"68","author":"X Ge","year":"2018","unstructured":"Ge X et al (2018) High mobility group box-1 drives fibrosis progression signaling via the receptor for advanced glycation end products in mice. Hepatology 68(6):2380\u20132404","journal-title":"Hepatology"},{"issue":"4","key":"5061_CR219","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1002\/hep.29623","volume":"67","author":"P Puri","year":"2018","unstructured":"Puri P et al (2018) The circulating microbiome signature and inferred functional metagenomics in alcoholic hepatitis. Hepatology 67(4):1284\u20131302","journal-title":"Hepatology"},{"issue":"36","key":"5061_CR220","doi-asserted-by":"publisher","first-page":"13079","DOI":"10.3748\/wjg.v20.i36.13079","volume":"20","author":"W Tang","year":"2014","unstructured":"Tang W et al (2014) Role of Nrf2 in chronic liver disease. World J Gastroenterol 20(36):13079\u201313087","journal-title":"World J Gastroenterol"},{"issue":"1","key":"5061_CR221","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM et al (2016) Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 64(1):73\u201384","journal-title":"Hepatology"},{"issue":"7","key":"5061_CR222","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0025-6196(24)00530-5","volume":"55","author":"J Ludwig","year":"1980","unstructured":"Ludwig J et al (1980) Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 55(7):434\u2013438","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"5061_CR223","doi-asserted-by":"publisher","first-page":"E131","DOI":"10.1152\/ajpendo.00181.2019","volume":"318","author":"Z Lu","year":"2020","unstructured":"Lu Z et al (2020) Amitriptyline inhibits nonalcoholic steatohepatitis and atherosclerosis induced by high-fat diet and LPS through modulation of sphingolipid metabolism. Am J Physiol Endocrinol Metab 318(2):E131-e144","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"11","key":"5061_CR224","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.3390\/cells9112458","volume":"9","author":"G Mazzolini","year":"2020","unstructured":"Mazzolini G et al (2020) Significance of simple steatosis: an update on the clinical and molecular evidence. Cells 9(11):2458","journal-title":"Cells"},{"issue":"2","key":"5061_CR225","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1055\/s-0029-1214375","volume":"29","author":"WK Syn","year":"2009","unstructured":"Syn WK et al (2009) Similarities and differences in the pathogenesis of alcoholic and nonalcoholic steatohepatitis. Semin Liver Dis 29(2):200\u2013210","journal-title":"Semin Liver Dis"},{"issue":"3","key":"5061_CR226","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1002\/hep.21752","volume":"46","author":"S Joshi-Barve","year":"2007","unstructured":"Joshi-Barve S et al (2007) Palmitic acid induces production of proinflammatory cytokine interleukin-8 from hepatocytes. Hepatology 46(3):823\u2013830","journal-title":"Hepatology"},{"issue":"17","key":"5061_CR227","doi-asserted-by":"publisher","first-page":"12093","DOI":"10.1074\/jbc.M510660200","volume":"281","author":"H Malhi","year":"2006","unstructured":"Malhi H et al (2006) Free fatty acids induce JNK-dependent hepatocyte lipoapoptosis. J Biol Chem 281(17):12093\u201312101","journal-title":"J Biol Chem"},{"issue":"1","key":"5061_CR228","doi-asserted-by":"publisher","first-page":"436","DOI":"10.3390\/ijms22010436","volume":"22","author":"M Dallio","year":"2021","unstructured":"Dallio M et al (2021) Immunity as cornerstone of non-alcoholic fatty liver disease: the contribution of oxidative stress in the disease progression. Int J Mol Sci 22(1):436","journal-title":"Int J Mol Sci"},{"issue":"Suppl 6","key":"5061_CR229","doi-asserted-by":"publisher","first-page":"s15","DOI":"10.7861\/clinmedicine.13-6-s15","volume":"13","author":"WK Syn","year":"2013","unstructured":"Syn WK (2013) Repair-associated inflammation in nonalcoholic fatty liver disease. Clin Med (Lond) 13(Suppl 6):s15\u2013s19","journal-title":"Clin Med (Lond)"},{"issue":"4","key":"5061_CR230","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/S0016-5085(98)70599-2","volume":"114","author":"CP Day","year":"1998","unstructured":"Day CP, James OF (1998) Steatohepatitis: a tale of two \u201chits\u201d? Gastroenterology 114(4):842\u2013845","journal-title":"Gastroenterology"},{"issue":"3","key":"5061_CR231","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13622","volume":"52","author":"A Karkucinska-Wieckowska","year":"2022","unstructured":"Karkucinska-Wieckowska A et al (2022) Mitochondria, oxidative stress and nonalcoholic fatty liver disease: a complex relationship. Eur J Clin Invest 52(3):e13622","journal-title":"Eur J Clin Invest"},{"issue":"2","key":"5061_CR232","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1080\/03602532.2017.1293683","volume":"49","author":"E Cobbina","year":"2017","unstructured":"Cobbina E, Akhlaghi F (2017) Non-alcoholic fatty liver disease (NAFLD)\u2014pathogenesis, classification, and effect on drug metabolizing enzymes and transporters. Drug Metab Rev 49(2):197\u2013211","journal-title":"Drug Metab Rev"},{"issue":"8","key":"5061_CR233","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","volume":"65","author":"E Buzzetti","year":"2016","unstructured":"Buzzetti E, Pinzani M, Tsochatzis EA (2016) The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism 65(8):1038\u20131048","journal-title":"Metabolism"},{"issue":"10","key":"5061_CR234","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1111\/liv.15024","volume":"41","author":"G Semmler","year":"2021","unstructured":"Semmler G et al (2021) Diet and exercise in NAFLD\/NASH: beyond the obvious. Liver Int 41(10):2249\u20132268","journal-title":"Liver Int"},{"issue":"1","key":"5061_CR235","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00018-018-2947-0","volume":"76","author":"F Bessone","year":"2019","unstructured":"Bessone F, Razori MV, Roma MG (2019) Molecular pathways of nonalcoholic fatty liver disease development and progression. Cell Mol Life Sci 76(1):99\u2013128","journal-title":"Cell Mol Life Sci"},{"issue":"4","key":"5061_CR236","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1111\/j.2042-7158.2011.01256.x","volume":"63","author":"T Ma","year":"2011","unstructured":"Ma T et al (2011) Hepatoprotective effects of geniposide in a rat model of nonalcoholic steatohepatitis. J Pharm Pharmacol 63(4):587\u2013593","journal-title":"J Pharm Pharmacol"},{"issue":"10","key":"5061_CR237","doi-asserted-by":"publisher","first-page":"5375","DOI":"10.3390\/ijms22105375","volume":"22","author":"A Di Ciaula","year":"2021","unstructured":"Di Ciaula A et al (2021) Nonalcoholic fatty liver disease (NAFLD). Mitochondria as players and targets of therapies? Int J Mol Sci 22(10):5375","journal-title":"Int J Mol Sci"},{"issue":"2","key":"5061_CR238","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/toxsci\/65.2.166","volume":"65","author":"H Jaeschke","year":"2002","unstructured":"Jaeschke H et al (2002) Mechanisms of hepatotoxicity. Toxicol Sci 65(2):166\u2013176","journal-title":"Toxicol Sci"},{"issue":"30","key":"5061_CR239","doi-asserted-by":"publisher","first-page":"21256","DOI":"10.1074\/jbc.M510644200","volume":"281","author":"BJ Kim","year":"2006","unstructured":"Kim BJ, Ryu SW, Song BJ (2006) JNK- and p38 kinase-mediated phosphorylation of Bax leads to its activation and mitochondrial translocation and to apoptosis of human hepatoma HepG2 cells. J Biol Chem 281(30):21256\u201321265","journal-title":"J Biol Chem"},{"issue":"3","key":"5061_CR240","doi-asserted-by":"publisher","first-page":"536","DOI":"10.3390\/antiox11030536","volume":"11","author":"E Rauchbach","year":"2022","unstructured":"Rauchbach E et al (2022) Cholesterol induces oxidative stress, mitochondrial damage and death in hepatic stellate cells to mitigate liver fibrosis in mice model of NASH. Antioxidants (Basel) 11(3):536","journal-title":"Antioxidants (Basel)"},{"key":"5061_CR241","doi-asserted-by":"crossref","unstructured":"Xie J et al (2022) The associations between modifiable risk factors and nonalcoholic fatty liver disease: a comprehensive Mendelian randomization study. Hepatology","DOI":"10.1002\/hep.32728"},{"key":"5061_CR242","doi-asserted-by":"publisher","first-page":"6613827","DOI":"10.1155\/2021\/6613827","volume":"2021","author":"M Maru\u0161i\u0107","year":"2021","unstructured":"Maru\u0161i\u0107 M et al (2021) NAFLD, insulin resistance, and diabetes mellitus type 2. Can J Gastroenterol Hepatol 2021:6613827","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"1","key":"5061_CR243","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s11894-011-0234-4","volume":"14","author":"JE Nelson","year":"2012","unstructured":"Nelson JE, Klintworth H, Kowdley KV (2012) Iron metabolism in nonalcoholic fatty liver disease. Curr Gastroenterol Rep 14(1):8\u201316","journal-title":"Curr Gastroenterol Rep"},{"key":"5061_CR244","doi-asserted-by":"publisher","first-page":"39764","DOI":"10.1038\/srep39764","volume":"7","author":"MA Abdelmegeed","year":"2017","unstructured":"Abdelmegeed MA et al (2017) Cytochrome P450-2E1 promotes fast food-mediated hepatic fibrosis. Sci Rep 7:39764","journal-title":"Sci Rep"},{"issue":"5","key":"5061_CR245","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1053\/gast.2000.19267","volume":"119","author":"K Cope","year":"2000","unstructured":"Cope K, Risby T, Diehl AM (2000) Increased gastrointestinal ethanol production in obese mice: implications for fatty liver disease pathogenesis. Gastroenterology 119(5):1340\u20131347","journal-title":"Gastroenterology"},{"key":"5061_CR246","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1476-9255-7-15","volume":"7","author":"AL Harte","year":"2010","unstructured":"Harte AL et al (2010) Elevated endotoxin levels in non-alcoholic fatty liver disease. J Inflamm (Lond) 7:15","journal-title":"J Inflamm (Lond)"},{"issue":"6","key":"5061_CR247","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1053\/j.gastro.2014.01.020","volume":"146","author":"B Schnabl","year":"2014","unstructured":"Schnabl B, Brenner DA (2014) Interactions between the intestinal microbiome and liver diseases. Gastroenterology 146(6):1513\u20131524","journal-title":"Gastroenterology"},{"issue":"1","key":"5061_CR248","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3945\/ajcn.116.131110","volume":"105","author":"A Damms-Machado","year":"2017","unstructured":"Damms-Machado A et al (2017) Gut permeability is related to body weight, fatty liver disease, and insulin resistance in obese individuals undergoing weight reduction. Am J Clin Nutr 105(1):127\u2013135","journal-title":"Am J Clin Nutr"},{"issue":"7","key":"5061_CR249","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1136\/gutjnl-2016-311571","volume":"65","author":"L Zhu","year":"2016","unstructured":"Zhu L et al (2016) Gut microbiota produce alcohol and contribute to NAFLD. Gut 65(7):1232","journal-title":"Gut"},{"issue":"2","key":"5061_CR250","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.jhep.2006.08.025","volume":"46","author":"A Dela Pe\u00f1a","year":"2007","unstructured":"Dela Pe\u00f1a A et al (2007) NADPH oxidase is not an essential mediator of oxidative stress or liver injury in murine MCD diet-induced steatohepatitis. J Hepatol 46(2):304\u2013313","journal-title":"J Hepatol"},{"issue":"5","key":"5061_CR251","first-page":"601","volume":"44","author":"NC Davis","year":"1924","unstructured":"Davis NC (1924) The influence of diet upon the liver injury produced by carbon tetrachloride. J Med Res 44(5):601-614.3","journal-title":"J Med Res"},{"issue":"1","key":"5061_CR252","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/path.1711560106","volume":"156","author":"A Bosma","year":"1988","unstructured":"Bosma A et al (1988) Synergism between ethanol and carbon tetrachloride in the generation of liver fibrosis. J Pathol 156(1):15\u201321","journal-title":"J Pathol"},{"issue":"1","key":"5061_CR253","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1006\/taap.1998.8547","volume":"153","author":"FW Wong","year":"1998","unstructured":"Wong FW, Chan WY, Lee SS (1998) Resistance to carbon tetrachloride-induced hepatotoxicity in mice which lack CYP2E1 expression. Toxicol Appl Pharmacol 153(1):109\u2013118","journal-title":"Toxicol Appl Pharmacol"},{"issue":"3","key":"5061_CR254","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3390\/ph15030369","volume":"15","author":"HM Alkreathy","year":"2022","unstructured":"Alkreathy HM, Esmat A (2022) lycorine ameliorates thioacetamide-induced hepatic fibrosis in rats: emphasis on antioxidant, anti-inflammatory, and STAT3 inhibition effects. Pharmaceuticals (Basel) 15(3):369","journal-title":"Pharmaceuticals (Basel)"},{"key":"5061_CR255","first-page":"2841894","volume":"2022","author":"N Enciso","year":"2022","unstructured":"Enciso N et al (2022) Model of liver fibrosis induction by thioacetamide in rats for regenerative therapy studies. Anal Cell Pathol (Amst) 2022:2841894","journal-title":"Anal Cell Pathol (Amst)"},{"key":"5061_CR256","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3389\/fphar.2016.00481","volume":"7","author":"S Ghosh","year":"2016","unstructured":"Ghosh S et al (2016) Silymarin protects mouse liver and kidney from thioacetamide induced toxicity by scavenging reactive oxygen species and activating PI3K-Akt pathway. Front Pharmacol 7:481","journal-title":"Front Pharmacol"},{"issue":"11","key":"5061_CR257","doi-asserted-by":"publisher","first-page":"4017","DOI":"10.3390\/ijms21114017","volume":"21","author":"P Schyman","year":"2020","unstructured":"Schyman P et al (2020) Concordance between thioacetamide-induced liver injury in rat and human in vitro gene expression data. Int J Mol Sci 21(11):4017","journal-title":"Int J Mol Sci"},{"issue":"4","key":"5061_CR258","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1139\/cjpp-2017-0247","volume":"96","author":"SAE Bashandy","year":"2018","unstructured":"Bashandy SAE et al (2018) Role of zinc oxide nanoparticles in alleviating hepatic fibrosis and nephrotoxicity induced by thioacetamide in rats. Can J Physiol Pharmacol 96(4):337\u2013344","journal-title":"Can J Physiol Pharmacol"},{"issue":"3","key":"5061_CR259","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.taap.2007.11.010","volume":"228","author":"JS Kang","year":"2008","unstructured":"Kang JS et al (2008) Role of CYP2E1 in thioacetamide-induced mouse hepatotoxicity. Toxicol Appl Pharmacol 228(3):295\u2013300","journal-title":"Toxicol Appl Pharmacol"},{"issue":"1","key":"5061_CR260","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1038\/s41467-023-37459-z","volume":"14","author":"Q Zhao","year":"2023","unstructured":"Zhao Q et al (2023) Parabacteroides distasonis ameliorates hepatic fibrosis potentially via modulating intestinal bile acid metabolism and hepatocyte pyroptosis in male mice. Nat Commun 14(1):1829","journal-title":"Nat Commun"},{"issue":"3","key":"5061_CR261","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1074\/mcp.RA118.000817","volume":"18","author":"Q Zhao","year":"2019","unstructured":"Zhao Q et al (2019) Celastrol protects from cholestatic liver injury through modulation of SIRT1-FXR signaling. Mol Cell Proteomics 18(3):520\u2013533","journal-title":"Mol Cell Proteomics"},{"issue":"11","key":"5061_CR262","doi-asserted-by":"publisher","first-page":"867","DOI":"10.2174\/1389200220666191105121653","volume":"20","author":"R Mohi-Ud-Din","year":"2019","unstructured":"Mohi-Ud-Din R et al (2019) Possible pathways of hepatotoxicity caused by chemical agents. Curr Drug Metab 20(11):867\u2013879","journal-title":"Curr Drug Metab"},{"key":"5061_CR263","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/bs.apha.2019.02.001","volume":"85","author":"MR McGill","year":"2019","unstructured":"McGill MR, Jaeschke H (2019) Biomarkers of drug-induced liver injury. Adv Pharmacol 85:221\u2013239","journal-title":"Adv Pharmacol"},{"issue":"9","key":"5061_CR264","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1038\/ajg.2012.138","volume":"107","author":"KT Suk","year":"2012","unstructured":"Suk KT et al (2012) A prospective nationwide study of drug-induced liver injury in Korea. Am J Gastroenterol 107(9):1380\u20131387","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"5061_CR265","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1002\/hep.28323","volume":"63","author":"ES Bj\u00f6rnsson","year":"2016","unstructured":"Bj\u00f6rnsson ES, Hoofnagle JH (2016) Categorization of drugs implicated in causing liver injury: critical assessment based on published case reports. Hepatology 63(2):590\u2013603","journal-title":"Hepatology"},{"issue":"4","key":"5061_CR266","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.mcna.2008.03.005","volume":"92","author":"RJ Fontana","year":"2008","unstructured":"Fontana RJ (2008) Acute liver failure including acetaminophen overdose. Med Clin North Am 92(4):761\u2013794","journal-title":"Med Clin North Am"},{"issue":"9","key":"5061_CR267","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1089\/ars.2021.0102","volume":"35","author":"A Ramachandran","year":"2021","unstructured":"Ramachandran A, Jaeschke H (2021) Oxidant stress and acetaminophen hepatotoxicity: mechanism-based drug development. Antioxid Redox Signal 35(9):718\u2013733","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"5061_CR268","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3727\/105221617X15084371374138","volume":"18","author":"A Ramachandran","year":"2018","unstructured":"Ramachandran A, Jaeschke H (2018) Acetaminophen toxicity: novel insights into mechanisms and future perspectives. Gene Expr 18(1):19\u201330","journal-title":"Gene Expr"},{"issue":"2","key":"5061_CR269","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1055\/s-0039-1679919","volume":"39","author":"A Ramachandran","year":"2019","unstructured":"Ramachandran A, Jaeschke H (2019) Acetaminophen hepatotoxicity. Semin Liver Dis 39(2):221\u2013234","journal-title":"Semin Liver Dis"},{"key":"5061_CR270","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.redox.2016.10.001","volume":"10","author":"K Du","year":"2016","unstructured":"Du K, Ramachandran A, Jaeschke H (2016) Oxidative stress during acetaminophen hepatotoxicity: sources, pathophysiological role and therapeutic potential. Redox Biol 10:148\u2013156","journal-title":"Redox Biol"},{"issue":"13","key":"5061_CR271","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.3748\/wjg.v24.i13.1373","volume":"24","author":"H Ye","year":"2018","unstructured":"Ye H et al (2018) Dissecting the molecular pathophysiology of drug-induced liver injury. World J Gastroenterol 24(13):1373\u20131385","journal-title":"World J Gastroenterol"},{"issue":"Suppl 1","key":"5061_CR272","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1002\/cld.984","volume":"16","author":"WM Lee","year":"2020","unstructured":"Lee WM (2020) Acetaminophen toxicity: a history of serendipity and unintended consequences. Clin Liver Dis (Hoboken) 16(Suppl 1):34\u201344","journal-title":"Clin Liver Dis (Hoboken)"},{"issue":"1","key":"5061_CR273","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0378-4274(96)03831-3","volume":"90","author":"AM Matthews","year":"1997","unstructured":"Matthews AM et al (1997) Comparison of covalent binding of acetaminophen and the regioisomer 3\u2032-hydroxyacetanilide to mouse liver protein. Toxicol Lett 90(1):77\u201382","journal-title":"Toxicol Lett"},{"issue":"1","key":"5061_CR274","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/hep.510300104","volume":"30","author":"SL Michael","year":"1999","unstructured":"Michael SL et al (1999) Pretreatment of mice with macrophage inactivators decreases acetaminophen hepatotoxicity and the formation of reactive oxygen and nitrogen species. Hepatology 30(1):186\u2013195","journal-title":"Hepatology"},{"issue":"6","key":"5061_CR275","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.1002\/hep.32083","volume":"74","author":"S Win","year":"2021","unstructured":"Win S et al (2021) Hepatic mitochondrial SAB deletion or knockdown alleviates diet-induced metabolic syndrome, steatohepatitis, and hepatic fibrosis. Hepatology 74(6):3127\u20133145","journal-title":"Hepatology"},{"key":"5061_CR276","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/bs.apha.2019.01.007","volume":"85","author":"A Ramachandran","year":"2019","unstructured":"Ramachandran A, Jaeschke H (2019) Acetaminophen hepatotoxicity: a mitochondrial perspective. Adv Pharmacol 85:195\u2013219","journal-title":"Adv Pharmacol"},{"issue":"1","key":"5061_CR277","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1053\/j.gastro.2006.03.045","volume":"131","author":"BK Gunawan","year":"2006","unstructured":"Gunawan BK et al (2006) c-Jun N-terminal kinase plays a major role in murine acetaminophen hepatotoxicity. Gastroenterology 131(1):165\u2013178","journal-title":"Gastroenterology"},{"issue":"4","key":"5061_CR278","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1053\/j.gastro.2008.08.031","volume":"135","author":"N Kaplowitz","year":"2008","unstructured":"Kaplowitz N et al (2008) How to protect against acetaminophen: don\u2019t ask for JUNK. Gastroenterology 135(4):1047\u20131051","journal-title":"Gastroenterology"},{"issue":"20","key":"5061_CR279","doi-asserted-by":"publisher","first-page":"13565","DOI":"10.1074\/jbc.M708916200","volume":"283","author":"N Hanawa","year":"2008","unstructured":"Hanawa N et al (2008) Role of JNK translocation to mitochondria leading to inhibition of mitochondria bioenergetics in acetaminophen-induced liver injury. J Biol Chem 283(20):13565\u201313577","journal-title":"J Biol Chem"},{"key":"5061_CR280","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2023.116452","volume":"465","author":"X He","year":"2023","unstructured":"He X et al (2023) Mitoquinone protects against acetaminophen-induced liver injury in an FSP1-dependent and GPX4-independent manner. Toxicol Appl Pharmacol 465:116452","journal-title":"Toxicol Appl Pharmacol"},{"issue":"1","key":"5061_CR281","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3390\/livers3010003","volume":"3","author":"K Begriche","year":"2023","unstructured":"Begriche K et al (2023) Acetaminophen-induced hepatotoxicity in obesity and nonalcoholic fatty liver disease: a critical review. Livers 3(1):33\u201353","journal-title":"Livers"},{"issue":"3","key":"5061_CR282","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1001\/jama.1980.03310030027020","volume":"244","author":"CJ McClain","year":"1980","unstructured":"McClain CJ et al (1980) Potentiation of acetaminophen hepatotoxicity by alcohol. JAMA 244(3):251\u2013253","journal-title":"JAMA"},{"issue":"5","key":"5061_CR283","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1002\/hep.31747","volume":"73","author":"WM Lee","year":"2021","unstructured":"Lee WM, Kaplowitz N (2021) Alcohol, fasting, and therapeutic dosing of acetaminophen: a perfect storm. Hepatology 73(5):1634\u20131636","journal-title":"Hepatology"},{"issue":"17","key":"5061_CR284","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.3390\/cells11172620","volume":"11","author":"S Kumar","year":"2022","unstructured":"Kumar S et al (2022) Hepatic, extrahepatic and extracellular vesicle cytochrome P450 2E1 in alcohol and acetaminophen-mediated adverse interactions and potential treatment options. Cells 11(17):2620","journal-title":"Cells"},{"issue":"4","key":"5061_CR285","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1046\/j.1365-2125.2000.00167.x","volume":"49","author":"LF Prescott","year":"2000","unstructured":"Prescott LF (2000) Paracetamol, alcohol and the liver. Br J Clin Pharmacol 49(4):291\u2013301","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"5061_CR286","doi-asserted-by":"publisher","first-page":"399","DOI":"10.7326\/0003-4819-104-3-399","volume":"104","author":"LB Seeff","year":"1986","unstructured":"Seeff LB et al (1986) Acetaminophen hepatotoxicity in alcoholics. A therapeutic misadventure. Ann Intern Med 104(3):399\u2013404","journal-title":"Ann Intern Med"},{"issue":"16","key":"5061_CR287","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1056\/NEJM199710163371602","volume":"337","author":"FV Schi\u00f8dt","year":"1997","unstructured":"Schi\u00f8dt FV et al (1997) Acetaminophen toxicity in an urban county hospital. N Engl J Med 337(16):1112\u20131117","journal-title":"N Engl J Med"},{"issue":"23","key":"5061_CR288","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1001\/jama.1994.03520230055038","volume":"272","author":"DC Whitcomb","year":"1994","unstructured":"Whitcomb DC, Block GD (1994) Association of acetaminophen hepatotoxicity with fasting and ethanol use. JAMA 272(23):1845\u20131850","journal-title":"JAMA"},{"issue":"5","key":"5061_CR289","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1002\/hep.31678","volume":"73","author":"A Louvet","year":"2021","unstructured":"Louvet A et al (2021) Acute liver injury with therapeutic doses of acetaminophen: a prospective study. Hepatology 73(5):1945\u20131955","journal-title":"Hepatology"},{"issue":"4","key":"5061_CR290","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.bpg.2013.08.001","volume":"27","author":"P Pateria","year":"2013","unstructured":"Pateria P, de Boer B, MacQuillan G (2013) Liver abnormalities in drug and substance abusers. Best Pract Res Clin Gastroenterol 27(4):577\u2013596","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"33","key":"5061_CR291","doi-asserted-by":"publisher","first-page":"5601","DOI":"10.2174\/092986712803988938","volume":"19","author":"MJ Valente","year":"2012","unstructured":"Valente MJ et al (2012) Contribution of oxidative metabolism to cocaine-induced liver and kidney damage. Curr Med Chem 19(33):5601\u20135606","journal-title":"Curr Med Chem"},{"issue":"4","key":"5061_CR292","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1080\/10915810305117","volume":"22","author":"R Labib","year":"2003","unstructured":"Labib R, Turkall R, Abdel-Rahman MS (2003) Endotoxin potentiates cocaine-mediated hepatotoxicity by nitric oxide and reactive oxygen species. Int J Toxicol 22(4):305\u2013316","journal-title":"Int J Toxicol"},{"issue":"1","key":"5061_CR293","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0041-008X(92)90210-J","volume":"117","author":"RA Dean","year":"1992","unstructured":"Dean RA et al (1992) Effects of ethanol on cocaine metabolism: formation of cocaethylene and norcocaethylene. Toxicol Appl Pharmacol 117(1):1\u20138","journal-title":"Toxicol Appl Pharmacol"},{"issue":"2","key":"5061_CR294","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.toxlet.2009.03.023","volume":"188","author":"VV Upreti","year":"2009","unstructured":"Upreti VV et al (2009) Drug interaction between ethanol and 3,4-methylenedioxymethamphetamine (\u201cecstasy\u201d). Toxicol Lett 188(2):167\u2013172","journal-title":"Toxicol Lett"},{"key":"5061_CR295","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.biochi.2018.12.009","volume":"158","author":"HN Mai","year":"2019","unstructured":"Mai HN et al (2019) Genetic depletion of p53 attenuates cocaine-induced hepatotoxicity in mice. Biochimie 158:53\u201361","journal-title":"Biochimie"},{"issue":"5","key":"5061_CR296","doi-asserted-by":"publisher","first-page":"476","DOI":"10.2174\/138920110791591535","volume":"11","author":"M Carvalho","year":"2010","unstructured":"Carvalho M et al (2010) Mechanisms underlying the hepatotoxic effects of ecstasy. Curr Pharm Biotechnol 11(5):476\u2013495","journal-title":"Curr Pharm Biotechnol"},{"issue":"3","key":"5061_CR297","doi-asserted-by":"publisher","first-page":"232","DOI":"10.4037\/aacnacc2019852","volume":"30","author":"RJM Cajanding","year":"2019","unstructured":"Cajanding RJM (2019) MDMA-associated liver toxicity: pathophysiology, management, and current state of knowledge. AACN Adv Crit Care 30(3):232\u2013248","journal-title":"AACN Adv Crit Care"},{"issue":"7","key":"5061_CR298","first-page":"3461","volume":"11","author":"TW Mudd","year":"2021","unstructured":"Mudd TW, Guddati AK (2021) Management of hepatotoxicity of chemotherapy and targeted agents. Am J Cancer Res 11(7):3461\u20133474","journal-title":"Am J Cancer Res"},{"key":"5061_CR299","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.112328","volume":"144","author":"N Abd Rashid","year":"2021","unstructured":"Abd Rashid N et al (2021) The role of natural antioxidants in cisplatin-induced hepatotoxicity. Biomed Pharmacother 144:112328","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"5061_CR300","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s00280-017-3358-x","volume":"80","author":"JCF Quintanilha","year":"2017","unstructured":"Quintanilha JCF et al (2017) Involvement of cytochrome P450 in cisplatin treatment: implications for toxicity. Cancer Chemother Pharmacol 80(2):223\u2013233","journal-title":"Cancer Chemother Pharmacol"},{"issue":"1","key":"5061_CR301","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12967-021-02814-5","volume":"19","author":"S Gong","year":"2021","unstructured":"Gong S et al (2021) Gut microbiota accelerates cisplatin-induced acute liver injury associated with robust inflammation and oxidative stress in mice. J Transl Med 19(1):147","journal-title":"J Transl Med"},{"issue":"12","key":"5061_CR302","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1038\/s41401-021-00620-9","volume":"42","author":"CY Fang","year":"2021","unstructured":"Fang CY et al (2021) Natural products: potential treatments for cisplatin-induced nephrotoxicity. Acta Pharmacol Sin 42(12):1951\u20131969","journal-title":"Acta Pharmacol Sin"},{"issue":"2","key":"5061_CR303","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1093\/toxsci\/kfj031","volume":"89","author":"Y Lu","year":"2006","unstructured":"Lu Y, Cederbaum AI (2006) Cisplatin-induced hepatotoxicity is enhanced by elevated expression of cytochrome P450 2E1. Toxicol Sci 89(2):515\u2013523","journal-title":"Toxicol Sci"},{"issue":"6","key":"5061_CR304","doi-asserted-by":"publisher","first-page":"825","DOI":"10.3390\/antiox10060825","volume":"10","author":"EE Eltamany","year":"2021","unstructured":"Eltamany EE et al (2021) The antioxidant Carrichtera annua DC. Ethanolic extract counteracts cisplatin triggered hepatic and renal toxicities. Antioxidants (Basel) 10(6):825","journal-title":"Antioxidants (Basel)"},{"key":"5061_CR305","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2022.112970","volume":"163","author":"T Sun","year":"2022","unstructured":"Sun T et al (2022) Melatonin attenuates cisplatin-induced acute kidney injury in mice: involvement of PPAR\u03b1 and fatty acid oxidation. Food Chem Toxicol 163:112970","journal-title":"Food Chem Toxicol"},{"key":"5061_CR306","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.freeradbiomed.2020.01.003","volume":"148","author":"DB Hwang","year":"2020","unstructured":"Hwang DB et al (2020) Ccrn4l as a pre-dose marker for prediction of cisplatin-induced hepatotoxicity susceptibility. Free Radic Biol Med 148:128\u2013139","journal-title":"Free Radic Biol Med"},{"key":"5061_CR307","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111670","volume":"139","author":"BG Eid","year":"2021","unstructured":"Eid BG, El-Shitany NA (2021) Captopril downregulates expression of Bax\/cytochrome C\/caspase-3 apoptotic pathway, reduces inflammation, and oxidative stress in cisplatin-induced acute hepatic injury. Biomed Pharmacother 139:111670","journal-title":"Biomed Pharmacother"},{"key":"5061_CR308","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.tox.2018.07.009","volume":"409","author":"F Paech","year":"2018","unstructured":"Paech F et al (2018) Sunitinib induces hepatocyte mitochondrial damage and apoptosis in mice. Toxicology 409:13\u201323","journal-title":"Toxicology"},{"issue":"1","key":"5061_CR309","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jceh.2012.12.001","volume":"3","author":"V Ramappa","year":"2013","unstructured":"Ramappa V, Aithal GP (2013) Hepatotoxicity related to anti-tuberculosis drugs: mechanisms and management. J Clin Exp Hepatol 3(1):37\u201349","journal-title":"J Clin Exp Hepatol"},{"issue":"4","key":"5061_CR310","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1111\/jgh.12516","volume":"29","author":"UA Boelsterli","year":"2014","unstructured":"Boelsterli UA, Lee KK (2014) Mechanisms of isoniazid-induced idiosyncratic liver injury: emerging role of mitochondrial stress. J Gastroenterol Hepatol 29(4):678\u2013687","journal-title":"J Gastroenterol Hepatol"},{"key":"5061_CR311","doi-asserted-by":"crossref","unstructured":"Ezhilarasan D (2023) Antitubercular drugs induced liver injury: an updated insight into molecular mechanisms. Drug Metab Rev 1\u201315","DOI":"10.1080\/03602532.2023.2215478"},{"key":"5061_CR312","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.chemosphere.2019.04.026","volume":"227","author":"ZL Jia","year":"2019","unstructured":"Jia ZL et al (2019) Mechanism of isoniazid-induced hepatotoxicity in zebrafish larvae: activation of ROS-mediated ERS, apoptosis and the Nrf2 pathway. Chemosphere 227:541\u2013550","journal-title":"Chemosphere"},{"issue":"3","key":"5061_CR313","doi-asserted-by":"publisher","first-page":"207","DOI":"10.2174\/1574886311308030011","volume":"8","author":"SH Park","year":"2013","unstructured":"Park SH, Ishino R (2013) Liver injury associated with antidepressants. Curr Drug Saf 8(3):207\u2013223","journal-title":"Curr Drug Saf"},{"issue":"3","key":"5061_CR314","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s00204-020-02963-4","volume":"95","author":"N Todorovi\u0107 Vukoti\u0107","year":"2021","unstructured":"Todorovi\u0107 Vukoti\u0107 N et al (2021) Antidepressants- and antipsychotics-induced hepatotoxicity. Arch Toxicol 95(3):767\u2013789","journal-title":"Arch Toxicol"},{"issue":"12","key":"5061_CR315","doi-asserted-by":"publisher","DOI":"10.5812\/hepatmon.41564","volume":"16","author":"P Carrier","year":"2016","unstructured":"Carrier P et al (2016) Liver illness and psychiatric patients. Hepat Mon 16(12):e41564","journal-title":"Hepat Mon"},{"issue":"9","key":"5061_CR316","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1002\/hep4.1541","volume":"4","author":"C Labenz","year":"2020","unstructured":"Labenz C et al (2020) Nonalcoholic fatty liver disease increases the risk of anxiety and depression. Hepatol Commun 4(9):1293\u20131301","journal-title":"Hepatol Commun"},{"issue":"8","key":"5061_CR317","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.3390\/cells11081362","volume":"11","author":"S Sonali","year":"2022","unstructured":"Sonali S et al (2022) Mechanistic insights into the link between gut dysbiosis and major depression: an extensive review. Cells 11(8):1362","journal-title":"Cells"},{"key":"5061_CR318","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2021.107988","volume":"231","author":"SB Chidambaram","year":"2022","unstructured":"Chidambaram SB et al (2022) Gut dysbiosis, defective autophagy and altered immune responses in neurodegenerative diseases: tales of a vicious cycle. Pharmacol Ther 231:107988","journal-title":"Pharmacol Ther"},{"key":"5061_CR319","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.toxlet.2023.05.008","volume":"383","author":"PFV Bizerra","year":"2023","unstructured":"Bizerra PFV et al (2023) The harmful acute effects of clomipramine in the rat liver: impairments in mitochondrial bioenergetics. Toxicol Lett 383:1\u201316","journal-title":"Toxicol Lett"},{"issue":"10","key":"5061_CR320","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1111\/j.1572-0241.2002.06041.x","volume":"97","author":"D Yadav","year":"2002","unstructured":"Yadav D et al (2002) Serum and liver micronutrient antioxidants and serum oxidative stress in patients with chronic hepatitis C. Am J Gastroenterol 97(10):2634\u20132639","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"5061_CR321","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1111\/j.1478-3231.2008.01720.x","volume":"28","author":"M Ando","year":"2008","unstructured":"Ando M et al (2008) Mitochondrial electron transport inhibition in full genomic hepatitis C virus replicon cells is restored by reducing viral replication. Liver Int 28(8):1158\u20131166","journal-title":"Liver Int"},{"issue":"1","key":"5061_CR322","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1053\/j.gastro.2004.10.045","volume":"128","author":"K Otani","year":"2005","unstructured":"Otani K et al (2005) Hepatitis C virus core protein, cytochrome P450 2E1, and alcohol produce combined mitochondrial injury and cytotoxicity in hepatoma cells. Gastroenterology 128(1):96\u2013107","journal-title":"Gastroenterology"},{"issue":"Suppl 1","key":"5061_CR323","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/hep.31288","volume":"73","author":"KA McGlynn","year":"2021","unstructured":"McGlynn KA, Petrick JL, El-Serag HB (2021) Epidemiology of hepatocellular carcinoma. Hepatology 73(Suppl 1):4\u201313","journal-title":"Hepatology"},{"issue":"2","key":"5061_CR324","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1053\/j.gastro.2018.08.065","volume":"156","author":"L Kulik","year":"2019","unstructured":"Kulik L, El-Serag HB (2019) Epidemiology and management of hepatocellular carcinoma. Gastroenterology 156(2):477-491.e1","journal-title":"Gastroenterology"},{"issue":"1","key":"5061_CR325","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12929-017-0327-y","volume":"24","author":"JS Chang","year":"2017","unstructured":"Chang JS, Hsiao JR, Chen CH (2017) ALDH2 polymorphism and alcohol-related cancers in Asians: a public health perspective. J Biomed Sci 24(1):19","journal-title":"J Biomed Sci"},{"issue":"3","key":"5061_CR326","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000050","volume":"6","author":"PJ Brooks","year":"2009","unstructured":"Brooks PJ et al (2009) The alcohol flushing response: an unrecognized risk factor for esophageal cancer from alcohol consumption. PLoS Med 6(3):e50","journal-title":"PLoS Med"},{"issue":"11","key":"5061_CR327","first-page":"5319","volume":"11","author":"S Yao","year":"2021","unstructured":"Yao S et al (2021) ALDH2 is a prognostic biomarker and related with immune infiltrates in HCC. Am J Cancer Res 11(11):5319\u20135337","journal-title":"Am J Cancer Res"},{"issue":"2","key":"5061_CR328","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/ijc.1585","volume":"97","author":"KS Park","year":"2002","unstructured":"Park KS et al (2002) Proteomic alterations of the variants of human aldehyde dehydrogenase isozymes correlate with hepatocellular carcinoma. Int J Cancer 97(2):261\u2013265","journal-title":"Int J Cancer"},{"issue":"10","key":"5061_CR329","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1002\/pmic.200300562","volume":"3","author":"YM Cho","year":"2003","unstructured":"Cho YM et al (2003) Differential expression of the liver proteome in senescence accelerated mice. Proteomics 3(10):1883\u20131894","journal-title":"Proteomics"},{"issue":"24","key":"5061_CR330","doi-asserted-by":"publisher","first-page":"4142","DOI":"10.1002\/elps.200290032","volume":"23","author":"J Kim","year":"2002","unstructured":"Kim J et al (2002) Proteome analysis of human liver tumor tissue by two-dimensional gel electrophoresis and matrix assisted laser desorption\/ionization-mass spectrometry for identification of disease-related proteins. Electrophoresis 23(24):4142\u20134156","journal-title":"Electrophoresis"},{"issue":"4","key":"5061_CR331","doi-asserted-by":"publisher","first-page":"736","DOI":"10.3350\/cmh.2020.0203","volume":"26","author":"M Taniai","year":"2020","unstructured":"Taniai M (2020) Alcohol and hepatocarcinogenesis. Clin Mol Hepatol 26(4):736\u2013741","journal-title":"Clin Mol Hepatol"},{"key":"5061_CR332","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/978-3-030-22254-3_6","volume":"1164","author":"BJ Song","year":"2019","unstructured":"Song BJ et al (2019) Contributing roles of CYP2E1 and other cytochrome p450 isoforms in alcohol-related tissue injury and carcinogenesis. Adv Exp Med Biol 1164:73\u201387","journal-title":"Adv Exp Med Biol"},{"issue":"8","key":"5061_CR333","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1093\/carcin\/19.8.1383","volume":"19","author":"A Yokoyama","year":"1998","unstructured":"Yokoyama A et al (1998) Alcohol-related cancers and aldehyde dehydrogenase-2 in Japanese alcoholics. Carcinogenesis 19(8):1383\u20131387","journal-title":"Carcinogenesis"},{"issue":"4","key":"5061_CR334","first-page":"211","volume":"4","author":"CP Stice","year":"2018","unstructured":"Stice CP, Xia H, Wang XD (2018) Tomato lycopene prevention of alcoholic fatty liver disease and hepatocellular carcinoma development. Chronic Dis Transl Med 4(4):211\u2013224","journal-title":"Chronic Dis Transl Med"},{"issue":"4","key":"5061_CR335","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1136\/gutjnl-2021-324727","volume":"71","author":"N Hohmann","year":"2022","unstructured":"Hohmann N et al (2022) Clomethiazole inhibits cytochrome P450 2E1 and improves alcoholic liver disease. Gut 71(4):842\u2013844","journal-title":"Gut"},{"issue":"10","key":"5061_CR336","doi-asserted-by":"publisher","first-page":"5170","DOI":"10.3390\/ijms22105170","volume":"22","author":"SY Liu","year":"2021","unstructured":"Liu SY, Tsai IT, Hsu YC (2021) Alcohol-related liver disease: basic mechanisms and clinical perspectives. Int J Mol Sci 22(10):5170","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5061_CR337","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1002\/hep.30036","volume":"69","author":"FR Ponziani","year":"2019","unstructured":"Ponziani FR et al (2019) Hepatocellular carcinoma is associated with gut microbiota profile and inflammation in nonalcoholic fatty liver disease. Hepatology 69(1):107\u2013120","journal-title":"Hepatology"},{"issue":"5","key":"5061_CR338","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1016\/j.jceh.2022.02.001","volume":"12","author":"G Ayares","year":"2022","unstructured":"Ayares G et al (2022) Current medical treatment for alcohol-associated liver disease. J Clin Exp Hepatol 12(5):1333\u20131348","journal-title":"J Clin Exp Hepatol"},{"key":"5061_CR339","doi-asserted-by":"crossref","unstructured":"Devarbhavi H et al (2023) Global burden of liver disease: 2023 update. J Hepatol","DOI":"10.1016\/j.jhep.2023.03.017"},{"issue":"1","key":"5061_CR340","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/hep.30866","volume":"71","author":"DW Crabb","year":"2020","unstructured":"Crabb DW et al (2020) Diagnosis and treatment of alcohol-associated liver diseases: 2019 practice guidance from the American Association for the Study of Liver Diseases. Hepatology 71(1):306\u2013333","journal-title":"Hepatology"},{"issue":"6","key":"5061_CR341","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/S0016-5085(99)70506-8","volume":"116","author":"CA Matteoni","year":"1999","unstructured":"Matteoni CA et al (1999) Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 116(6):1413\u20131419","journal-title":"Gastroenterology"},{"issue":"3","key":"5061_CR342","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1053\/jhep.2002.31782","volume":"35","author":"B Raynard","year":"2002","unstructured":"Raynard B et al (2002) Risk factors of fibrosis in alcohol-induced liver disease. Hepatology 35(3):635\u2013638","journal-title":"Hepatology"},{"issue":"6","key":"5061_CR343","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1002\/hep.29631","volume":"67","author":"F \u00c5berg","year":"2018","unstructured":"\u00c5berg F et al (2018) Interaction between alcohol consumption and metabolic syndrome in predicting severe liver disease in the general population. Hepatology 67(6):2141\u20132149","journal-title":"Hepatology"},{"key":"5061_CR344","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c1240","volume":"340","author":"CL Hart","year":"2010","unstructured":"Hart CL et al (2010) Effect of body mass index and alcohol consumption on liver disease: analysis of data from two prospective cohort studies. BMJ 340:c1240","journal-title":"BMJ"},{"issue":"3","key":"5061_CR345","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1002\/hep.30867","volume":"71","author":"Y Chang","year":"2020","unstructured":"Chang Y et al (2020) Low levels of alcohol consumption, obesity, and development of fatty liver with and without evidence of advanced fibrosis. Hepatology 71(3):861\u2013873","journal-title":"Hepatology"},{"issue":"1","key":"5061_CR346","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/hep.32312","volume":"76","author":"JH Lewis","year":"2022","unstructured":"Lewis JH (2022) Digitizing DILI: who can? RUCAM? RECAM? Hepatology 76(1):3\u20135","journal-title":"Hepatology"},{"issue":"3","key":"5061_CR347","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1007\/s00535-017-1415-1","volume":"53","author":"Y Sumida","year":"2018","unstructured":"Sumida Y, Yoneda M (2018) Current and future pharmacological therapies for NAFLD\/NASH. J Gastroenterol 53(3):362\u2013376","journal-title":"J Gastroenterol"},{"key":"5061_CR348","doi-asserted-by":"publisher","DOI":"10.3389\/frai.2021.638410","volume":"4","author":"A Vall","year":"2021","unstructured":"Vall A et al (2021) The promise of AI for DILI prediction. Front Artif Intell 4:638410","journal-title":"Front Artif Intell"},{"issue":"6","key":"5061_CR349","doi-asserted-by":"publisher","first-page":"824","DOI":"10.3390\/biom12060824","volume":"12","author":"F Nassir","year":"2022","unstructured":"Nassir F (2022) NAFLD: mechanisms, treatments, and biomarkers. Biomolecules 12(6):824","journal-title":"Biomolecules"},{"issue":"4","key":"5061_CR350","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1002\/hep.26156","volume":"57","author":"D Kim","year":"2013","unstructured":"Kim D et al (2013) Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States. Hepatology 57(4):1357\u20131365","journal-title":"Hepatology"},{"issue":"36","key":"5061_CR351","doi-asserted-by":"publisher","first-page":"6549","DOI":"10.3748\/wjg.v23.i36.6549","volume":"23","author":"S Singh","year":"2017","unstructured":"Singh S, Osna NA, Kharbanda KK (2017) Treatment options for alcoholic and non-alcoholic fatty liver disease: a review. World J Gastroenterol 23(36):6549\u20136570","journal-title":"World J Gastroenterol"},{"issue":"4","key":"5061_CR352","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1002\/hep.32478","volume":"76","author":"G Szabo","year":"2022","unstructured":"Szabo G et al (2022) IL-1 receptor antagonist plus pentoxifylline and zinc for severe alcohol-associated hepatitis. Hepatology 76(4):1058\u20131068","journal-title":"Hepatology"},{"issue":"16","key":"5061_CR353","doi-asserted-by":"publisher","first-page":"4975","DOI":"10.3748\/wjg.v21.i16.4975","volume":"21","author":"F Higuera-de la Tijera","year":"2015","unstructured":"Higuera-de la Tijera F et al (2015) Metadoxine improves the three- and six-month survival rates in patients with severe alcoholic hepatitis. World J Gastroenterol 21(16):4975\u20134985","journal-title":"World J Gastroenterol"},{"issue":"5","key":"5061_CR354","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.jhep.2021.06.019","volume":"75","author":"JP Arab","year":"2021","unstructured":"Arab JP et al (2021) Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: a worldwide study. J Hepatol 75(5):1026\u20131033","journal-title":"J Hepatol"},{"key":"5061_CR355","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jnutbio.2018.05.003","volume":"59","author":"V Vatsalya","year":"2018","unstructured":"Vatsalya V et al (2018) Association of serum zinc with markers of liver injury in very heavy drinking alcohol-dependent patients. J Nutr Biochem 59:49\u201355","journal-title":"J Nutr Biochem"},{"issue":"1","key":"5061_CR356","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/hep4.1123","volume":"2","author":"S Liangpunsakul","year":"2018","unstructured":"Liangpunsakul S et al (2018) Interaction between the patatin-like phospholipase domain-containing protein 3 genotype and coffee drinking and the risk for acute alcoholic hepatitis. Hepatol Commun 2(1):29\u201334","journal-title":"Hepatol Commun"},{"issue":"10","key":"5061_CR357","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1111\/acer.13862","volume":"42","author":"N Samala","year":"2018","unstructured":"Samala N et al (2018) Posttraumatic stress disorder in patients with heavy alcohol consumption and alcoholic hepatitis. Alcohol Clin Exp Res 42(10):1933\u20131938","journal-title":"Alcohol Clin Exp Res"},{"issue":"1","key":"5061_CR358","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jceh.2022.10.002","volume":"13","author":"M Hernandez-Tejero","year":"2023","unstructured":"Hernandez-Tejero M, Clemente-Sanchez A, Bataller R (2023) Spectrum, screening, and diagnosis of alcohol-related liver disease. J Clin Exp Hepatol 13(1):75\u201387","journal-title":"J Clin Exp Hepatol"},{"issue":"10","key":"5061_CR359","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.3390\/biomedicines10102530","volume":"10","author":"Y Ha","year":"2022","unstructured":"Ha Y, Jeong I, Kim TH (2022) Alcohol-related liver disease: an overview on pathophysiology, diagnosis and therapeutic perspectives. Biomedicines 10(10):2530","journal-title":"Biomedicines"},{"issue":"1","key":"5061_CR360","doi-asserted-by":"publisher","first-page":"13","DOI":"10.35946\/arcr.v42.1.13","volume":"42","author":"R Ramkissoon","year":"2022","unstructured":"Ramkissoon R, Shah VH (2022) Alcohol use disorder and alcohol-associated liver disease. Alcohol Res 42(1):13","journal-title":"Alcohol Res"},{"issue":"4","key":"5061_CR361","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1053\/j.gastro.2015.12.038","volume":"150","author":"C Moreno","year":"2016","unstructured":"Moreno C et al (2016) Intensive enteral nutrition is ineffective for patients with severe alcoholic hepatitis treated with corticosteroids. Gastroenterology 150(4):903\u201310.e8","journal-title":"Gastroenterology"},{"issue":"5","key":"5061_CR362","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.cmet.2017.04.001","volume":"25","author":"R Loomba","year":"2017","unstructured":"Loomba R et al (2017) Gut microbiome-based metagenomic signature for non-invasive detection of advanced fibrosis in human nonalcoholic fatty liver disease. Cell Metab 25(5):1054-1062.e5","journal-title":"Cell Metab"},{"issue":"1","key":"5061_CR363","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.apsb.2019.11.017","volume":"10","author":"T Yan","year":"2020","unstructured":"Yan T et al (2020) Herbal drug discovery for the treatment of nonalcoholic fatty liver disease. Acta Pharm Sin B 10(1):3\u201318","journal-title":"Acta Pharm Sin B"},{"issue":"9","key":"5061_CR364","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.3390\/nu10091153","volume":"10","author":"AFG Cicero","year":"2018","unstructured":"Cicero AFG, Colletti A, Bellentani S (2018) Nutraceutical approach to non-alcoholic fatty liver disease (NAFLD): the available clinical evidence. Nutrients 10(9):1153","journal-title":"Nutrients"},{"issue":"24","key":"5061_CR365","doi-asserted-by":"publisher","first-page":"8855","DOI":"10.3390\/molecules27248855","volume":"27","author":"W Yang","year":"2022","unstructured":"Yang W et al (2022) Silymarin protects against acute liver injury induced by acetaminophen by downregulating the expression and activity of the CYP2E1 enzyme. Molecules 27(24):8855","journal-title":"Molecules"},{"key":"5061_CR366","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.fct.2018.11.012","volume":"123","author":"DD Luo","year":"2019","unstructured":"Luo DD et al (2019) Tetrahydrocurcumin and octahydrocurcumin, the primary and final hydrogenated metabolites of curcumin, possess superior hepatic-protective effect against acetaminophen-induced liver injury: role of CYP2E1 and Keap1-Nrf2 pathway. Food Chem Toxicol 123:349\u2013362","journal-title":"Food Chem Toxicol"},{"issue":"2","key":"5061_CR367","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1093\/carcin\/17.2.277","volume":"17","author":"S Barcelo","year":"1996","unstructured":"Barcelo S et al (1996) CYP2E1-mediated mechanism of anti-genotoxicity of the broccoli constituent sulforaphane. Carcinogenesis 17(2):277\u2013282","journal-title":"Carcinogenesis"},{"key":"5061_CR368","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.943321","volume":"13","author":"Z Cui","year":"2022","unstructured":"Cui Z et al (2022) Therapeutic application of quercetin in aging-related diseases: SIRT1 as a potential mechanism. Front Immunol 13:943321","journal-title":"Front Immunol"},{"key":"5061_CR369","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.pharmthera.2018.03.004","volume":"188","author":"H Dai","year":"2018","unstructured":"Dai H et al (2018) Sirtuin activators and inhibitors: promises, achievements, and challenges. Pharmacol Ther 188:140\u2013154","journal-title":"Pharmacol Ther"},{"issue":"3","key":"5061_CR370","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.jhep.2016.11.004","volume":"66","author":"T Ramirez","year":"2017","unstructured":"Ramirez T et al (2017) Aging aggravates alcoholic liver injury and fibrosis in mice by downregulating sirtuin 1 expression. J Hepatol 66(3):601\u2013609","journal-title":"J Hepatol"},{"issue":"2","key":"5061_CR371","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1007\/s12020-012-9761-5","volume":"43","author":"Y Li","year":"2013","unstructured":"Li Y et al (2013) Administration of ghrelin improves inflammation, oxidative stress, and apoptosis during and after non-alcoholic fatty liver disease development. Endocrine 43(2):376\u2013386","journal-title":"Endocrine"},{"issue":"20","key":"5061_CR372","doi-asserted-by":"publisher","first-page":"11397","DOI":"10.1021\/acs.jmedchem.0c00524","volume":"63","author":"BH Norman","year":"2020","unstructured":"Norman BH (2020) Drug induced liver injury (DILI). Mechanisms and medicinal chemistry avoidance\/mitigation strategies. J Med Chem 63(20):11397\u201311419","journal-title":"J Med Chem"},{"issue":"4","key":"5061_CR373","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1586\/17474124.2016.1127756","volume":"10","author":"JG Stine","year":"2016","unstructured":"Stine JG, Lewis JH (2016) Current and future directions in the treatment and prevention of drug-induced liver injury: a systematic review. Expert Rev Gastroenterol Hepatol 10(4):517\u2013536","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"5061_CR374","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.bcp.2018.11.020","volume":"160","author":"I Grattagliano","year":"2019","unstructured":"Grattagliano I et al (2019) Targeting mitochondria to oppose the progression of nonalcoholic fatty liver disease. Biochem Pharmacol 160:34\u201345","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"5061_CR375","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.jcmgh.2019.04.007","volume":"8","author":"WP Esler","year":"2019","unstructured":"Esler WP, Bence KK (2019) Metabolic targets in nonalcoholic fatty liver disease. Cell Mol Gastroenterol Hepatol 8(2):247\u2013267","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"5061_CR376","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1196\/annals.1427.019","volume":"1147","author":"S Leo","year":"2008","unstructured":"Leo S, Szabadkai G, Rizzuto R (2008) The mitochondrial antioxidants MitoE(2) and MitoQ(10) increase mitochondrial Ca(2+) load upon cell stimulation by inhibiting Ca(2+) efflux from the organelle. Ann NY Acad Sci 1147:264\u2013274","journal-title":"Ann NY Acad Sci"},{"key":"5061_CR377","doi-asserted-by":"crossref","unstructured":"Sulaimon LA et al (2021) Molecular mechanism of mitoquinol mesylate in mitigating the progression of hepatocellular carcinoma-in silico and in vivo studies. J Cell Biochem","DOI":"10.1002\/jcb.29937"},{"issue":"11","key":"5061_CR378","first-page":"1382","volume":"25","author":"R Virgana","year":"2022","unstructured":"Virgana R et al (2022) MitoTEMPOL modulates mitophagy and histopathology of Wistar rat liver after streptozotocin injection. Iran J Basic Med Sci 25(11):1382\u20131388","journal-title":"Iran J Basic Med Sci"},{"key":"5061_CR379","doi-asserted-by":"crossref","unstructured":"Zapata J et al (2022) Targeting mitochondria for the prevention and treatment of nonalcoholic fatty liver disease: polyphenols as a non-pharmacological approach. Curr Med Chem 30(26):2977-2995","DOI":"10.2174\/0929867329666221007115809"},{"issue":"9","key":"5061_CR380","doi-asserted-by":"publisher","first-page":"4727","DOI":"10.1002\/ptr.7104","volume":"35","author":"X Zhao","year":"2021","unstructured":"Zhao X et al (2021) Quercetin as a protective agent for liver diseases: a comprehensive descriptive review of the molecular mechanism. Phytother Res 35(9):4727\u20134747","journal-title":"Phytother Res"},{"key":"5061_CR381","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111326","volume":"137","author":"K Wang","year":"2021","unstructured":"Wang K et al (2021) New insight and potential therapy for NAFLD: CYP2E1 and flavonoids. Biomed Pharmacother 137:111326","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"5061_CR382","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1600-079X.2006.00356.x","volume":"41","author":"T Matsura","year":"2006","unstructured":"Matsura T et al (2006) Mechanisms of protection by melatonin against acetaminophen-induced liver injury in mice. J Pineal Res 41(3):211\u2013219","journal-title":"J Pineal Res"},{"issue":"12","key":"5061_CR383","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0051911","volume":"7","author":"YL Liang","year":"2012","unstructured":"Liang YL et al (2012) Melatonin protects against apoptosis-inducing factor (AIF)-dependent cell death during acetaminophen-induced acute liver failure. PLoS ONE 7(12):e51911","journal-title":"PLoS ONE"},{"issue":"5","key":"5061_CR384","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/jez.1917","volume":"323","author":"P Madhu","year":"2015","unstructured":"Madhu P, Reddy KP, Reddy PS (2015) Melatonin reduces oxidative stress and restores mitochondrial function in the liver of rats exposed to chemotherapeutics. J Exp Zool A Ecol Genet Physiol 323(5):301\u2013308","journal-title":"J Exp Zool A Ecol Genet Physiol"},{"key":"5061_CR385","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.freeradbiomed.2018.10.402","volume":"130","author":"C Luo","year":"2019","unstructured":"Luo C et al (2019) The multiple protective roles and molecular mechanisms of melatonin and its precursor N-acetylserotonin in targeting brain injury and liver damage and in maintaining bone health. Free Radic Biol Med 130:215\u2013233","journal-title":"Free Radic Biol Med"},{"issue":"4","key":"5061_CR386","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.3390\/ijms21041525","volume":"21","author":"T Kanda","year":"2020","unstructured":"Kanda T et al (2020) Molecular mechanisms: connections between nonalcoholic fatty liver disease, steatohepatitis and hepatocellular carcinoma. Int J Mol Sci 21(4):1525","journal-title":"Int J Mol Sci"},{"issue":"7932","key":"5061_CR387","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/s41586-022-05299-4","volume":"610","author":"B Chen","year":"2022","unstructured":"Chen B et al (2022) Gut bacteria alleviate smoking-related NASH by degrading gut nicotine. Nature 610(7932):562\u2013568","journal-title":"Nature"},{"issue":"1","key":"5061_CR388","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0080169","volume":"9","author":"Y Ritze","year":"2014","unstructured":"Ritze Y et al (2014) Lactobacillus rhamnosus GG protects against non-alcoholic fatty liver disease in mice. PLoS ONE 9(1):e80169","journal-title":"PLoS ONE"},{"issue":"5","key":"5061_CR389","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1136\/gutjnl-2016-313432","volume":"67","author":"C Grander","year":"2018","unstructured":"Grander C et al (2018) Recovery of ethanol-induced Akkermansia muciniphila depletion ameliorates alcoholic liver disease. Gut 67(5):891\u2013901","journal-title":"Gut"},{"issue":"3","key":"5061_CR390","doi-asserted-by":"publisher","first-page":"384","DOI":"10.3390\/antiox10030384","volume":"10","author":"JW Ballway","year":"2021","unstructured":"Ballway JW, Song BJ (2021) Translational approaches with antioxidant phytochemicals against alcohol-mediated oxidative stress, gut dysbiosis, intestinal barrier dysfunction, and fatty liver disease. Antioxidants (Basel) 10(3):384","journal-title":"Antioxidants (Basel)"},{"key":"5061_CR391","doi-asserted-by":"publisher","first-page":"6981721","DOI":"10.1155\/2023\/6981721","volume":"2023","author":"S Hao","year":"2023","unstructured":"Hao S et al (2023) Fecal microbiota transplantation research over the past decade: current status and trends. Can J Infect Dis Med Microbiol 2023:6981721","journal-title":"Can J Infect Dis Med Microbiol"},{"issue":"4","key":"5061_CR392","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s11154-019-09512-0","volume":"20","author":"M Schoeler","year":"2019","unstructured":"Schoeler M, Caesar R (2019) Dietary lipids, gut microbiota and lipid metabolism. Rev Endocr Metab Disord 20(4):461\u2013472","journal-title":"Rev Endocr Metab Disord"},{"issue":"5","key":"5061_CR393","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1093\/jn\/nxy324","volume":"149","author":"W Fang","year":"2019","unstructured":"Fang W et al (2019) Supplementation with sodium butyrate modulates the composition of the gut microbiota and ameliorates high-fat diet-induced obesity in mice. J Nutr 149(5):747\u2013754","journal-title":"J Nutr"},{"issue":"1","key":"5061_CR394","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.celrep.2014.02.032","volume":"7","author":"C Degirolamo","year":"2014","unstructured":"Degirolamo C et al (2014) Microbiota modification with probiotics induces hepatic bile acid synthesis via downregulation of the Fxr-Fgf15 axis in mice. Cell Rep 7(1):12\u201318","journal-title":"Cell Rep"},{"issue":"2","key":"5061_CR395","doi-asserted-by":"publisher","first-page":"e02210","DOI":"10.1128\/mBio.02210-15","volume":"7","author":"ML Chen","year":"2016","unstructured":"Chen ML et al (2016) Resveratrol attenuates trimethylamine-N-oxide (TMAO)-induced atherosclerosis by regulating TMAO synthesis and bile acid metabolism via remodeling of the gut microbiota. MBio 7(2):e02210-e2215","journal-title":"MBio"},{"issue":"14","key":"5061_CR396","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.202100014","volume":"65","author":"S Liu","year":"2021","unstructured":"Liu S et al (2021) Ligustrum robustum alleviates atherosclerosis by decreasing serum TMAO, modulating gut microbiota, and decreasing bile acid and cholesterol absorption in mice. Mol Nutr Food Res 65(14):e2100014","journal-title":"Mol Nutr Food Res"},{"issue":"1","key":"5061_CR397","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1034\/j.1600-079X.2003.00050.x","volume":"35","author":"G Sener","year":"2003","unstructured":"Sener G, Sehirli AO, Ayano\u011flu-D\u00fclger G (2003) Protective effects of melatonin, vitamin E and N-acetylcysteine against acetaminophen toxicity in mice: a comparative study. J Pineal Res 35(1):61\u201368","journal-title":"J Pineal Res"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-023-05061-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-023-05061-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-023-05061-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T17:55:59Z","timestamp":1731002159000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-023-05061-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,12]]},"references-count":397,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["5061"],"URL":"https:\/\/doi.org\/10.1007\/s00018-023-05061-7","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,12]]},"assertion":[{"value":"8 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors read this review article and have declared no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors read the current version of this article and agreed to publish it.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"34"}}